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This dissertation took steps towards filling major research gaps in lesbian health in the form of 
three manuscripts evaluating epidemiologic evidence for health disparities.  Although the health 
disparities explored were not closely related, each was based upon analysis of data collected as 
part of the ESTHER (Epidemiologic STudy of HEalth Risk in Women) Project, a large cross-
sectional study examining risk factors for coronary heart disease (CHD) among lesbian and 
heterosexual women living in the Pittsburgh, Pennsylvania area.  Data were collected between 
2003 and 2006, and these analyses were completed in 2009.  The first manuscript examined 
differences in complementary and alternative medicine (CAM) use between lesbian and 
heterosexual women.  Lesbians were more likely to have used CAM in their lifetime and within 
the past 12 months when compared to heterosexual women.  Among women who had used CAM 
within the past 12 months, the types of CAM reported did not vary by sexual orientation.  The 
second manuscript investigated the association between lesbian sexual orientation, sexual abuse 
history, and adulthood obesity.  Lesbian sexual orientation and a history of childhood sexual 
abuse (CSA) perpetrated by a family member were each independently associated with current 
adulthood obesity.  The third manuscript explored potential differences in the prevalence and 
associated factors of polycystic ovary syndrome (PCOS) by sexual orientation.  A small sample 
size limited the power of the analysis to confirm statistical difference in PCOS prevalence or 
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associated factors; however, meaningful trends were observed.  If the observed trends are 
reflective of the larger population, lesbians may exhibit differences in PCOS determinate factors, 
have higher rates of PCOS, and may be more likely to be diagnosed with PCOS compared to 
heterosexual women.  The public health significance of this dissertation was to explore potential 
health-related differences that may exist between heterosexual and lesbian women in the areas of 
CAM, obesity, and PCOS research.   Findings contributed to the literature on health disparities 
and provided further support for a greater focus on lesbian health, including public health 
training, education, screenings, and interventions to better serve the lesbian population.    
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PCOS when I first began my research.   
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given me valuable research and analytical advice, and has been a positive research mentor.  In 
addition, I would like to thank the Lambda Foundation and the ESTHER Project for funding the 
PCOS Study. 
I want to express my appreciation towards Lisa Campbell for her understanding, support, 
encouragement, and patience during the years when I pursued my Ph.D.  Yes, I will have more 
time to play now.  I would also like to recognize my family:  Nevin Smith (father), Bonnie Smith 
(mother), Ammie Smith (sister), grandparents, uncles, aunts, and cousins.  They have provided 
me with a stable foundation which has made it possible for me to pursue my interests in public 
health and in life. I am fortunate to have been raised, protected, and loved by them. I look 
forward to spending more time with each of them.   
 
1.0  INTRODUCTION 
Numerous reports by prestigious institutions including the National Institute of Mental Health 
(NIMH), Centers for Disease Control and Prevention (CDC), American Public Health 
Association (APHA) and the Institute of Medicine (IOM) have concluded that the state of 
healthcare knowledge concerning gays, lesbians, and bisexuals (GLB) is insufficient.1  Although 
there is a growing body of published literature addressing lesbian women’s health status, large 
gaps in the literature exist.  Studies to establish how and why health and disease risk factors; 
disease prevalence rates; and prevention, intervention, and treatment needs may differ by sexual 
orientation are necessary to improve the health and well-being of sexual minority groups.  Such 
studies would better inform healthcare providers and guide effective public health programs, 
improving the health of lesbian women.    
By focusing on potential health disparities that may exist between lesbian and 
heterosexual women, this dissertation seeks to contribute to the literature and document the 
health status of lesbian women.  Three epidemiologic manuscripts are presented, each based on 
data collected as part of the ESTHER (Epidemiologic STudy of HEalth Risk in Women) 
Project.  The first manuscript describes potential differences in complementary and alternative 
medicine (CAM) use between lesbian and heterosexual women.  The second manuscript 
examines the relationship between sexual orientation, lifetime sexual abuse, and current 
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adulthood obesity.  The final manuscript explores the prevalence and associated factors of 
polycystic ovary syndrome (PCOS) by sexual orientation group.   
Before the three manuscripts will be presented, a background with an introduction on 
lesbian health barriers, lesbian health research, and the ESTHER Project will be discussed.  
1.1 LESBIAN HEALTH BARRIERS 
Like other minority populations, lesbians are part of a socially stigmatized group where 
inequalities and health barriers are clearly present and may influence overall health and 
wellbeing.1 2  Some health-related concerns include economic barriers, no or inadequate 
insurance coverage, lack of lesbian partner recognition,3 and lack of lesbian-specific health 
promotion interventions.2  Many lesbians do not have the same health-related benefits or 
privileges as heterosexuals.  Lesbians are less likely to be insured than heterosexual women, 
partly because health insurance coverage cannot be obtained through partners; and lesbian 
partners can be denied hospital visitation rights and the ability to make medical decisions for ill 
partners.3 4 Lesbian households are likely to have lower average incomes than heterosexual 
partnered households, 5 6 reflective of a lower pay scale for women in general.7  Many traditional 
healthcare programs do not incorporate the specific health needs of lesbian populations, 
potentially because of the invisibility, thus lack of recognition, of this population.8  These 
barriers result in fewer health opportunities for lesbians, and may help explain why published 
findings indicate that lesbians are less likely to use preventative health services compared to 
heterosexual women.9-14    
 2 
Not all lesbians assume that healthcare settings are safe and that they will be treated with 
equality.  Research findings indicate that lesbians have had negative interactions within the 
healthcare system.  Nearly 27% of gays and lesbians have reported perceived discrimination in a 
healthcare setting because of their sexual orientation.15  Some lesbians have reported fears about 
coming “out” to physicians,16 which may have been confirmed by lesbians who sensed they were 
treated differently after disclosing their sexual orientation to a primary care physician.   It is 
difficult to determine the rate at which perceived discrimination based on sexual orientation can 
be proven; however, some published data supports these reports.   In 1982 approximately 22.9% 
of physicians who completed the Heterosexual Attitudes Towards Homosexuality (HATH) Scale 
demonstrated scores that reflected homophobia.17  A follow-up study conducted nearly two 
decades later found that although this rate had decreased, some physicians still presented 
homophobic attitudes towards patients (rate unreported).18    
Even when homophobia is not an issue, many physicians assume that patients are 
heterosexual and live heterosexual lives 19; however, with 2% to 6% of women in the United 
States reportedly engaging in sexual activity with other women, healthcare professionals are 
giving care to lesbians whether they know it are not. 3   Prior studies report that many lesbians 
feel that their healthcare has been hindered by this heterosexual assumption.10   Many physicians 
are supportive of lesbians; however, they cannot give women lesbian-specific health advice if 
patients do not reveal their sexual orientation.  Some lesbians are not aware of how a lesbian 
sexual orientation can influence an individual’s general health.   Perhaps reflective of the current 
state of knowledge regarding lesbian health, some may think that homosexuality does not 
influence health any differently than what heterosexuality influences health.  Therefore since 
they do not feel their sexuality is a pressing health issue, they do not present their sexual 
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orientation to their primary healthcare providers.  These barriers are obstacles that must be 
overcome in order to improve health education and the overall health of lesbians.  
1.2 LESBIAN HEALTH RESEARCH 
Next a brief discussion on lesbian health research history, barriers to research, research findings, 
and future research directions will be shared. 
1.2.1 History of Lesbian Research 
Interest in lesbian health disparities and health across the lifespan began to emerge in the mid 
1980s; prior to this, much lesbian research reflected attempts to explain why women became 
homosexual and explorations of psychological and social functioning.   In 1985 the first national 
lesbian health study was conducted, examining a broad range of lesbian health issues. Since then 
lesbian health research has been expanding, notably increasing after a round-table discussion in 
1994 that provided a lesbian health agenda and research priorities to the United States 
Department of Health and Human Services.20    
1.2.2 Barriers to Lesbian Health Research  
Like many other types of research focus areas, lesbian health research is influenced by political 
pressures, community attitudes, and funding availability.  Researchers, regardless of sexual 
orientation or gender, may hesitate to conduct lesbian health research because of the potential 
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negative impact that working with this socially stigmatized group could have on their careers. 
There are few institutions that financially support lesbian health research.  Other valid fears 
include potential lack of funding, and/or mentors with knowledge or who are willing to work 
with lesbian populations.1    
 Lesbian health research faces methodological barriers that make it difficult to conduct 
large scale studies.  Lesbian health research is often criticized for its lack of comparison groups, 
non-probability sampling methods, and lack of standard measurements of sexual orientation.21  
Sexual minority groups of women are often difficult to recruit; and are considered to be a 
“hidden population” as they are as heterogeneous as heterosexual women, reflecting a broad 
diversity as defined by socio-economic status, race/ethnicity, and other demographic factors.  
Because lesbian studies are often drawn from convenience samples, they do not represent the 
broad diversity of all lesbians.  The majority of published lesbian studies represent women who 
are: Caucasian, between the ages of 25 and 40, middle class, and well educated.  Thus, future 
research needs to capture potential health differences among lesbians of different age groups, 
racial/ethnic minority groups, socioeconomic classes, and geographic locations.21      
A significant barrier to generating comparative samples is related to the 
operationalization of “lesbian”.  This term is defined inconsistently across studies.  Many studies 
have used one or a combination of definitions covering same-sex attraction, sexual behavior, or 
self identification; however, these also have multiple ways of being defined, and therefore, are 
not mutually exclusive or perfectly correlated.    
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1.2.3 Discoveries of Lesbian Health Research  
Studies show that compared to heterosexual women, lesbians consistently report higher rates of 
the following health-related risk factors:  body mass index,13 14 22-24 cigarette smoking, 4 13 14 22-24 
and alcohol consumption.4 12 13 22 25   Despite being heavier, lesbians are more likely to report 
vigorous activity.13 14 22 24 26 27  Findings from studies focused on mental health disorders, such as 
depression and anxiety, have produced mixed results; however, it is recognized that social 
stigmatization, homophobia, and gay-related violence28 may foster development of certain 
conditions such as depression and anxiety.29  A recent meta-analysis found that lesbians and 
bisexual women had a higher lifetime and 12 month prevalence of depression and anxiety 
disorders, and risk of alcohol and drug dependence compared to heterosexual women.30   Certain 
health-related characteristics differ by sexual orientation, specifically lesbians are less likely to 
give birth to children and use oral contraceptives, and have more barriers to healthcare than 
heterosexual women.2   Furthermore, lesbians are more likely to report perceived discrimination 
in a medical establishment,15 not attend regular health screenings, 31 and not use programs 
available to the general public.9-14  Although cohort studies have not been reported, the higher 
rates of the health risk factors and behaviors noted above may elevate lesbians’ risk for 
developing diseases like diabetes, heart disease, and/or some cancers (ovarian and breast) which 
implicates a need for interventions to be targeted towards different sexual minority groups of 
women.    
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1.2.4 Future Directions of Lesbian Health Research 
In 1999 the Institute of Medicine (IOM) released an assessment report on the current state and 
future directions of lesbian health.  Three noted research priorities for future research among 
lesbians were to: (1) “better understand the physical and mental health status of lesbians and to 
determine whether there are health problems for which lesbians are at higher risk as well as 
conditions for which protective factors operate to reduce their health risk”; (2) “understand how 
to define sexual orientation in general and lesbian sexual orientation in particular and to better 
understand the diversity of the lesbian population” and (3) “to identify possible barriers to access 
to mental and physical health care services for lesbians and ways to increase their access to these 
services.”1   In the Healthy People 2010 Companion Document for Lesbian, Gay, Bisexual, and 
Transgender (LGBT) Health future lesbian health research directions were also addressed, 2 
many of which are similar to IOM recommendations, such as better sexual orientation screening 
tools and a broader representation of lesbian subpopulations. Detailed recommendations were 
provided specifically for: data and information systems; services; education and training; policy 
changes for on specific lesbian health concerns; and diseases such as obesity, violence, and 
cancer.  Another noted goal was to conduct longitudinal studies.2  To date the majority of 
published studies concerning lesbians have been cross-sectional, which produce descriptive 
reports, lacking the data required to assess causality.  Longitudinal cohort studies are necessary 
to better examine the impact of how sexual orientation influences health across a lifespan.   
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2.0  THE ESTHER PROJECT 
 
Figure 1.  The ESTHER Project’s Logo 
 
 
The ESTHER Project began as a cross-sectional survey collecting general health information on 
sexual minority women living in the Pittsburgh, Pennsylvania area.   Data collected through self-
administered anonymous surveys allowed investigators to document potential differences and 
health trends between lesbian and heterosexual women.  Their findings provided supportive data 
for a more comprehensive cross-sectional study examining risk factors for coronary heart disease 
(CHD) funded by the National Heart, Lung and Blood Institute (NHLBI).  
2.1 CROSS-SECTIONAL ESTHER SURVEY 
The intent of the ESTHER Project pilot study was to describe the general health status of sexual 
minority women living in the Pittsburgh, Pennsylvania area.   A total of 1,158 women completed 
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anonymous surveys between February and September in 1998.   The survey collected 
information including but not limited to: socio-demographic information, current nutrition and 
body size, mental health factors, and diagnosis of specific health conditions.  Approximately 
97.7% of the sample self identified as homosexual/gay/lesbian.  Results from this study indicated 
that lesbian women demonstrated higher rates of specific health risk factors compared to 
heterosexual women including overweight, cigarette use, alcohol consumption, and heavy 
alcohol consumption compared to a representative sample of heterosexual women.13  
2.2 CROSS-SECTIONAL ESTHER CLINICAL EXAMINATION STUDY 
Data from the ESTHER survey supported the need for a more intensive clinical investigation of 
potential differences in the prevalence and risk factors for CHD.  The specific aims of this study 
were to:  (1) determine if the prevalence of CHD risk factors differed by sexual orientation, and 
(2) assess potential overall patterns and clustering of risk factors, comparing lesbian and 
heterosexual women.  A diverse sample of 1084 women were recruited and consented into the 
study between 2003 and 2006; approximately half (N=503) were lesbian women.  Participants 
qualified for the ESTHER Project if they were heterosexual or lesbian, at least 35 years old, and 
had no previous history of heart disease (angina, heart attack, and stroke).  Sexual orientation 
was based on a combination of features including same-sex attraction, sexual behavior, and self-
identification.  Participants were scheduled for two clinic visits at University of Pittsburgh-
related facilities.  The first clinic visit consisted of:  (1) a series of standardized questionnaires; 
(2) a two week medicine history review; (3) a physical activity interview; (4) clinical and 
anthropometric measurements including blood  pressure,  waist and hip circumference, height, 
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weight, and bioelectrical impedance assessment of body composition, and (4) fasting 
venipuncture for analyses of lipid profiles, glucose, insulin, and measures of inflammation.  
Participants returned for a second clinical visit, having completed a 3-day food diary, 3-day 
pedometer assignment, nutrition questionnaire, and take home questionnaires.  The second clinic 
visit provided a Dual Energy X-ray Absorptiometry (DXA) scan of the hip, spine, and whole 
body to measure bone mineral density and body composition.   
For individuals interested in learning more about lesbian health and how health patterns 
and disparities differ by sexual orientation, this dataset has great potential for unlocking many 
unanswered research questions.  The ESTHER Project investigators, research staff, and 
participants made this dissertation and the future work resulting from this study possible.  
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3.0  PAPER ONE: SEXUAL ORIENTATION AND USE OF  
COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM): WOMEN ENROLLED 
IN THE ESTHER PROJECT 
Smith, HA1; Markovic, N1; Danielson, ME1; Matthews, A2; Youk A3; and Talbott, EO1 
1University of Pittsburgh, Graduate School of Public Health, Department of Epidemiology, Pittsburgh, PA 
2University of Illinois at Chicago, College of Nursing, Department of Health System Sciences, Chicago, IL  
3University of Pittsburgh, Graduate School of Public Health, Department of Biostatistics, Pittsburgh, PA 
 
Manuscript in preparation.   
3.1 ABSTRACT 
Objectives:  The prevalence of complementary and alternative medicine (CAM) use in the 
United States has steadily increased since the 1990’s to the current rate.  Very little information 
exists on how CAM use may differ based on sexual orientation.  Aims of this study were to 
determine the prevalence of CAM use in a community sample of women, identify the most 
common types of CAM use in the past 12 months, and to identify correlates of CAM use.  
Further aims were to determine whether and how CAM use may differ based on sexual 
orientation.  Study hypotheses were that the prevalence of CAM use would differ by sexual 
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orientation such that lesbians would be more likely to use CAM compared to heterosexual 
women. 
Methods:  Analyses were based on a large community based sample of healthy adult women 
(Total N=879, N=479 lesbians) women enrolled in the Epidemiologic STudy of HEalth Risk in 
Women (ESTHER) Project, a cross-sectional study that examined risk factors for heart disease 
conducted between 2003-3006 in Pittsburgh, PA.  Chi squared and Fisher’s exact tests, and 
univariate and multiple logistic regression analyses were implemented for analytical purposes.   
Results:  Among ESTHER participants the prevalence of ever used CAM was 49.8% and used 
CAM within the past 12 months was 42.4%.  When compared to heterosexual women, lesbians 
were more likely to have ever used CAM (Adjusted Odds Ratio (AOR) = 1.68 [95% Confidence 
Interval [CI]: 1.23, 2.28]) and to have used CAM in the past 12 months (AOR = 1.44 [CI: 1.06, 
1.97]).  Significant correlates of ever used CAM and used CAM within the past 12 months were 
similar:  a lesbian sexual orientation, being Caucasian, having a higher education level, reporting 
perceived discrimination in a medical establishment, living in a large city, having higher ratings 
of spirituality, and having a history of a diagnosed mental health disorder.  Having a healthcare 
provider that provides usual care was also significantly related to CAM use in the past 12 
months.  Among women who used CAM within the past 12 months, the types of CAM used did 
not differ based on sexual orientation except that heterosexual women were significantly more 
likely to have participated in yoga than lesbian women. 
Conclusions:  Sexual orientation is an important factor associated with understanding lifetime 
and past 12 month CAM use.  Because of the high prevalence of CAM use found in this study 
and knowing that some CAM therapies interfere with conventional medicine, medical 
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practitioners should be encouraged to inquire about the CAM practices of their female patients, 
particularly lesbians.   
3.2 INTRODUCTION 
Complementary and alternative medicine (CAM) refers to a variety of health practices 
considered outside the traditional domain of conventional western medicine.32  Since the 1990s 
rates of CAM use among Americans have increased steadily to the present estimated rate of 
38%. 32-34  In 1997 it was estimated that the total cost of CAM therapies in the United States 
ranged between $36-$46 billion.35  The extant research suggests that CAM use is associated with 
individual attempts to improve general health35 or to treat specific health conditions such as back 
pain36 or migraines.37  Research also indicates that CAM is often used among people with more 
life-threatening illnesses such as cancer 38 39 and the Human Immunodeficiency Virus/Acquired 
Immunodeficiency Syndrome (HIV/AIDS).40 41  
Types of CAM use defined by the National Center for Complementary and Alternative 
Medicine (NCCAM) include but are not limited to the following: whole medical systems 
(homeopathy, naturaopathy, traditional Chinese medicine, and Ayurveda); mind-body medicine 
(meditation, prayer, mental healing, and creative therapies using art, music, or dance as outlets); 
biologically based practices (herbs, herbal products, foods, and vitamins); manipulative and 
body-based practices (chiropracty, osteopathy, and massage); energy medicine (biofield 
therapies and bioelectromagnetic–based therapies).32  
Rates of participation in CAM therapies and the factors influencing decisions to initiate 
CAM use vary based on demographic variables.  For example, current statistics suggest that 
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women between the ages of 30 and 64 years are the primary consumers of CAM.42  In 1999 US 
women spent approximately $600 million on CAM therapies to relieve menopausal symptoms 
alone.43  Motivation to use CAM therapies has also been found to differ by race and ethnicity.  A 
study by Chao et al. found that when women were asked what influenced their decision to use 
CAM,  non-Hispanic Caucasian women noted personal beliefs, Mexican-American women cited 
the high cost of conventional medicine, and African American women reported something they 
read or heard on the radio or television.44 
Sexual orientation is another demographic factor that may influence overall prevalence 
rates and motivation for engagement in CAM use.  London et al. examined the use of an 
alternative therapist in the past 6 months among gay, lesbian, and heterosexual individuals with 
HIV/AIDS.  Combining the sexual orientation groups, researchers found that gay and lesbian 
patients were more likely to use CAM therapists than heterosexual patients (Adjusted Odds Ratio 
[AOR] = 1.95; 95% Confidence Interval [CI] = 1.25, 3.05).41  Another study by Matthews and 
her colleagues examined the relationship between lesbian sexual orientation and CAM use 
among a community sample of women.  They found that lesbians were significantly more likely 
to have ever used CAM therapies compared to their heterosexual counterparts (p=.039).  Other 
predictors of lifetime CAM use included less health-related worry (p=.019) and perceived 
discrimination in a healthcare setting (p=.014).42  In a study examining health histories and 
activities, lesbian women had higher mean scores on alternative dietary practices and the use of 
meditation/relaxation techniques when compared to heterosexual women; however these factors 
were not specifically defined as CAM use.45 
Numerous factors may contribute to higher levels of CAM use among lesbians.  For 
example, lesbians may face unique barriers to accessing culturally competent and appropriate 
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healthcare services that may increase the likelihood of engagement in CAM therapies including 
lower rates of health insurance coverage,46 lower average income levels, and higher rates of 
actual or perceived discrimination in health care settings.42 47  Lesbians are also believed to have 
a higher prevalence of health-related conditions that have been associated with increased CAM 
use such as depression and anxiety.30  Furthermore, because lesbians often go through a “coming 
out” process they have already gone outside the “conventional box” in a sense.  This experience 
may make them more open-minded about using unconventional medicine or therapies than 
heterosexual women.  
Preliminary data suggests that sexual orientation may play a role in the level of 
engagement in and the factors influencing CAM use among women.  However, additional 
research is needed to confirm these earlier results and to address limitations of previous studies 
examining the relationship between CAM use and sexual orientation including small sample 
sizes, definitions of lesbian sexual orientation, and definitions of CAM.  The specific aim of the 
current study was to estimate the prevalence and correlates of CAM use among a large 
community-based sample of women enrolled in a women’s health research project (The 
ESTHER Project).  Differences in lifetime and past year CAM use and specific CAM modalities 
were assessed.  In addition, correlates of CAM use were examined by sexual orientation.  Based 
on the available literature, it was hypothesized that lesbians would be more likely to use CAM 
than heterosexual women and that the predictors of CAM use would differ by sexual orientation.  
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3.3 METHODS 
3.3.1 Study Design and Data Collection 
The sample population for this analysis was selected from 1084 participants (N=503 lesbians) 
enrolled in the ESTHER (Epidemiologic Study of HEalth Risk in Women) Project at the 
University of Pittsburgh between 2003 and 2006.  The purpose of the ESTHER Project was to 
conduct a cross-sectional study that examined differences in risk factors for heart disease among 
women in the Pittsburgh, Pennsylvania area.  Participants in the ESTHER Project were recruited 
using a variety of methods shown to increase recruitment of hard-to-reach populations:  news 
and radio advertisements; health events; lesbian, gay, bisexual and transgender (LGBT) events 
and socials; and The University of Pittsburgh broadcast phone-message system.  Trained 
research staff conducted recruitment/screening calls and scheduled those who met eligibility 
criteria for two clinic visits as part of study participation.  The first visit was conducted at Magee 
Women’s hospital where a series of questionnaires, a physical activity interview, a two week 
medicine history interview, and blood draws were completed.  The second visit included a 
review of a completed 3-day food diary and a Dual Energy X-ray Absorptiometry (DXA) scan of 
the hip, spine, and whole body.  Participants were paid $50 for their time and participation.  All 
information used in this analysis was obtained from the recruitment call forms and 
questionnaires completed at the first clinic visit. 
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3.3.2 Study Population 
Participants were eligible to participate in the ESTHER Project if they were age 35 or older, 
identified as a lesbian or heterosexual woman, and had no previous history of heart disease 
(angina, heart attack, and stroke).  All instruments and the study protocol were approved by the 
Institutional Review Board at the University of Pittsburgh.  A signed written consent form was 
obtained from each participant. 
To solve the issue of disproportionate numbers of older heterosexuals compared to older 
lesbians only individuals who were <65 years of age were included in the present analysis.  
African American heterosexuals were randomly selected in the same proportion as African 
American lesbians recruited into the study because of disproportionately low accrual rates of 
African American lesbians.  A total of 879 women were selected for analysis:  38 African 
American lesbians, 441 Caucasian lesbians, 32 African American heterosexuals, and 368 
Caucasian heterosexuals.  Because of missing values the sample size for ever used CAM was 
N=878 and CAM use within the past 12 months was N=877. 
3.3.3 Measures 
Dependent Variables 
History of CAM Use:  History of CAM was examined in three ways.  The question, “Have you 
ever sought help from any type of alternative health services, such as traditional healing, 
acupuncture, massage, or herbal therapies? EXCLUDE CLERGY AND CHIROPRACTORS” 
was used to determine if participants had ever used CAM.  The question, “Have you ever sought 
help from any type of alternative health services in the last 12 months?” was used to determine if 
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CAM was used in the previous year.  If a participant answered yes to this question she was asked 
to select the types of CAM used in the past 12 months:  acupuncture, aromatherapy, biofeedback, 
herbal medicine, homeopathy, hypnosis, massage, meditation, reiki, relaxation techniques, 
therapeutic touch, yoga, and other.  
Independent Variables 
All independent variables for analysis were selected based on previous research and included 
demographic, health-related, and psychosocial variables.35 38 41 42 48-51 
Demographics:  Sexual orientation, age, and race were obtained from screening/recruitment 
forms.  Other demographic factors including years of education, total household income, health 
insurance coverage, and primary residence (large city, not large city) were taken from the 
questionnaires completed at the first clinic visit. 
Sexual Orientation:  Heterosexuals were defined as those who self-identified as heterosexual or 
straight and only had male sexual partners since the age of 18.  Lesbians were defined as those 
who did not identify as heterosexual or straight;  and only had emotional, physical, and romantic 
attractions within the past 5 years towards only or primarily women; or whose relationships 
within the past 5 years had been with only or primarily women.  
Discrimination in a Medical Establishment:  Three discrimination items based on race, 
gender, and sexual orientation examined perceived discrimination in a medical establishment.  A 
fourth variable was created that combined these into an “ever discriminated” variable.  Although 
each factor was examined separately, the new combined variable was used in the regression 
analysis. 
Spirituality:  Spirituality was measured with a scaled item ranging from 1 to 5 (1 - not spiritual 
at all to 5 - very spiritual) that asked the question, “To what extent do you consider yourself to be 
 18 
a spiritual person?”  For analytical purposes, spirituality was categorized as follows:  not at all 
or somewhat spiritual (1-3), spiritual (4), and very spiritual (5).  
Self-Rated Health Status:  Self-rated health status was determined from the question, “In 
general, how would you characterize your health?”  For the purposes of our analysis these 
responses were categorized into three options:  excellent (excellent, very good), good (good), and 
poor (fair, poor, and very poor). 
Routine Checkups:  Participants’ healthcare behaviors were examined by using the following 
two measures: (1) Ábout how long has it been since you last visited a doctor for a routine 
checkup?” (Within the past 12 months; greater than one year to less than two years ago; and 
greater than or equal to 2 years ago, or don’t know) and (2) “Do you have a clinic, doctor, nurse, 
or physician’s assistant who provides your usual health care?” (Yes/No).  
Health-Related Conditions and Illnesses:  The ESTHER Project created a list of diseases and 
conditions that were thought or known to be related to cardiovascular disease (CVD) or 
suspected to differ between lesbian and heterosexual women.  Participants were asked if they 
were ever given diagnoses by a healthcare provider of any of the listed conditions.  This list was 
used to examine if certain types of diseases or illnesses were associated with CAM use.  For 
purposes of analysis these illnesses were categorized into several groups:  heart-related 
conditions (high blood pressure, high cholesterol, high  triglycerides, obesity, diabetes, angina, 
heart attack, heart disease, stroke); cancer (breast cancer, lung cancer, ovarian cancer, cervical 
cancer, other cancer (specified); autoimmune disorders (over- or underactive thyroid, arthritis, 
osteoporosis/osteopenia, and autoimmune disease [e.g., lupus, rheumatoid arthritis]); respiratory 
illnesses (asthma, emphysema or chronic bronchitis); and mental health diagnoses (eating 
disorder [anorexia, bulimia], depression, anxiety).  Stomach ulcers could not be placed in any of 
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the categories so it was examined alone.  In addition to this list, participants were also asked if a 
healthcare provider had ever diagnosed them with HIV/AIDS.  Since HIV/AIDS has been 
associated with CAM use in other studies 40 41 52 we also investigated HIV/AIDS in our analysis.  
For CAM use within the past 12 months depression was also assessed by using the 10-item 
Center for Epidemiologic Studies Depression Scale (CES-D 10).  A score >10 suggests a 
clinically significant level of psychological distress.53 54 
3.3.4 Statistical Analysis 
Categorical variables were analyzed using Chi squared and Fisher’s exact tests and univariate 
analyses for comparison of proportions and statistical significance.  Variables included in 
regression models had p-values <0.25 in the univariate analyses.  Tests of collinearity were 
performed and variables that had a variance inflation factor (VIF) of greater than 10 were 
removed.  Backwards logistic regression models were used to examine the association between 
sexual orientation and CAM use adjusting for potential confounders.  Statistical significance for 
multiple logistic regression models was defined as p <0.05.  No significant and relevant 
interactions were found.  The Hosmer-Lemeshow statistic was used to evaluate the overall model 
fit.  All statistical analyses were performed using the SAS system for Windows, version 9.2 
(SAS Institute, Cary, North Carolina).  
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3.4 RESULTS 
The sample was 92.0% (N=809) Caucasian and 8.0% (N=70) African American.  Overall 
participants were highly educated with 65.3% of the sample having a bachelor’s degree or 
higher.  Approximately half the sample were identified as lesbian (54.5%, N=479).  Age, being 
African American, and household income did not significantly differ by sexual orientation.  The 
mean age of heterosexual women was 47.8 years and for lesbians was 47.4 years.  
Approximately 49.8% (N=437, 274 Lesbian) of the ESTHER participants reported they had used 
CAM services in their lifetime and about 42.4% (N=372, 227 lesbian) reported CAM use in the 
past 12 months. 
3.4.1 Univariate Analyses 
Lesbians were significantly more likely to have ever used CAM (57.3% vs. 40.8%; p <0.0001) 
and to have used CAM in the past 12 months (47.6% vs. 36.3%; p<0.001) when compared to 
heterosexual women (Tables 1 & 2).  Additional demographic variables significantly associated 
with ever having used CAM included:  older age, Caucasian race, higher education, and 
residence in a large city.  Other factors significantly associated with having ever used CAM 
included:  perceived discrimination in a medical establishment, having a provider of usual 
healthcare, and endorsement of higher levels of spirituality.  Significant self-reported medical 
conditions associated with ever used CAM were mental health related disorders, respiratory 
disorders, and stomach ulcers.  Autoimmune disorders approached significance (p=0.057) for a 
lifetime history of CAM use.  Having a history of cancer, HIV/AIDS, or hearth related 
conditions was not associated with lifetime CAM use. 
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Univariate results for CAM use within the past 12 months were very similar to ever 
having used CAM except that age and having been diagnosed with a respiratory disorder were 
not significantly associated with CAM use.  Autoimmune disorders (p=0.079) also approached 
significance for history of past year CAM use.  Of the women who reported CAM use within the 
past 12 months (N=372) there was little difference in the types of CAM used among 
heterosexual and lesbian women (Table 3).  The only significant difference in CAM modality 
used was higher rates of yoga (p=0.002) among heterosexual women compared to lesbians.  
Relaxation techniques (p=0.063) and aromatherapy (p=0.053) approached significance with 
heterosexual women using these modalities slightly more than lesbians.  The most common 
CAM modalities used by women were massage (71.4%), yoga (31.9%), meditation (25.4%), and 
herbal medicines (24.1%).  
3.4.2 Multivariate Analyses 
Multivariate logistic regression analysis concluded that sexual orientation (AOR = 1.68, 95% CI 
[1.23, 2.28]) was an independent predictor of having ever used CAM after adjusting for potential 
covariates (Table 4).  Other significant covariates associated with ever having used CAM 
included Caucasian race, more years of education, perceived experience of discrimination in a 
medical establishment, residence in a large city, being very  spiritual, and having a history of a 
diagnosed mental health disorder.  Age was not a significant predictor of ever having used CAM.  
No meaningful interactions were found.  The Hosmer-Lemeshow Goodness of Fit Test showed 
the main effects model is a good fit for the data (p=0.517). 
Logistic regression analysis for CAM use within the past 12 months produced similar 
results.  Lesbians were more likely to have used CAM in the past 12 months (AOR = 1.44, 95% 
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CI [1.06, 1.97] when compared to heterosexual women.  Factors significantly associated with 
CAM use in the past 12 months were similar to ever used CAM except for education.  Although 
education level was significant in both, some college was not considered to be significantly 
different from having a high school degree or less.  No meaningful interactions were found.  The 
Hosmer-Lemeshow Goodness of Fit Test showed the main effects model is a good fit for the data 
(p=0.88).  
 
3.5 DISCUSSION 
This analysis investigated CAM use among heterosexual and lesbian women in the Pittsburgh, 
PA area.  History of CAM use was measured by individual self-reports of having ever used 
CAM and having used CAM in the past 12 months.  Of those who used CAM in the past 12 
months specific CAM modalities used were examined.  The overall prevalence of ever used 
CAM was 49.8% and used CAM in the past 12 months was 42.4%, which fall within the range 
reported by other studies.34 35 48 55 56  After adjusting for other covariates, sexual orientation was 
found to be an independent predictor of CAM use ever and within the past 12 months.  This 
complements research published by Matthews et al. who found that a lesbian sexual orientation 
was a predictor of CAM use.42  Our results resembled the outcome of other studies in that CAM 
use was associated with:  Caucasian women51 57 58; increasing years of education35 51 59; and 
perceived experience of discrimination in a medical establishment.42  Being very spiritual was 
associated with CAM use (ever/past 12 months) in our study.  This was similar to other studies 
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that found CAM use to be associated with religiosity,60 prayer for health-related reasons,35 49 61 or 
spirituality.49   
Our results diverge from some published studies in several ways.  Age as a predictor of 
CAM use has revealed mixed results.51  Our results did not find age to be a significant predictor 
of CAM use after adjusting for other covariates.  This could be due to the limited age range (35 
to 65) in the ESTHER Project which overlaps with the average age range of CAM users.42  
Although people who reside in large cities have an equal62 or higher rate of CAM use35 it has not 
been proven to be a significant predictor of CAM use.  This analysis found that those who lived 
in large cities were more likely to use CAM (ever and past 12 months) than those who did not 
live in large cities.  Results also showed that those who had a provider of usual healthcare, 
compared to those who did not, were more likely to use CAM within the past 12 months.  When 
the history of health conditions was considered, having a mental health disorder was found to be 
associated with CAM use (ever and within the past 12 months).  This concurs with other studies 
that examined this relationship. 63 64  Significant (unadjusted) associations with having a history 
of autoimmune and respiratory disorders were found, however these were not considered to be 
significant after adjusting for other covariates.  Unlike many studies, our analysis did not find 
associations between having been diagnosed with cancer or HIV/AIDS and CAM use (ever and 
past 12 months). This may be due to the small number of individuals in our study who had been 
diagnosed with cancer (n=62) or HIV/AIDS (n=11).   
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3.6 LIMITATIONS 
It is difficult to compare CAM studies because there has been no standard set of CAM modalities 
used in research, and even when studies have similar lists of CAM options they are often 
grouped differently for analytical purposes.  Our results should be taken with caution when 
compared` to other studies.  The present analysis did not include chiropractic services or 
religious prayer in the definition of CAM, which both typically increase the prevalence of CAM 
use.  CAM studies also vary in the following ways:  the timeline selected to examine CAM use 34 
42 48; whether CAM is defined by self-prescribed use34 48 or by a CAM practitioner40; whether 
participants use CAM in conjunction with or in place of conventional medicine34 48; and if the 
subject population is from a general34 48 or clinical population.40 62  
This study has a few limitations.  Lesbians in our analysis represent women who were 
comfortable revealing their sexual orientation and romantic/sexual relationships.  Therefore 
study results represent “out” lesbians.  Also, it should be assumed that lesbian couples were in 
the present study.  This may represent a sample bias because lesbian couples may have more 
similar responses to each other compared to the rest of the sample.   In addition, our results 
primarily describe CAM use among older Caucasian women.  Although the study included 
African American women, they only accounted for 8.0% of the total sample and no other 
minority groups were represented.  Lastly, because the data were taken from a cross-sectional 
study, we can only describe associations and cannot predict why women decide to use CAM.  A 
longitudinal study describing CAM use over time would be more appropriate to answer this 
question.  
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3.7 CONCLUSIONS 
The results of this study indicate that lesbians are more likely to have ever used CAM and to 
have used CAM in the past 12 months when compared to heterosexual women.  Therefore sexual 
orientation may play a role in understanding why some women choose to use CAM.  Since it is 
known that some CAM modalities may interfere with the effectiveness or may even have adverse 
health effects when used with conventional medicine, it is important for healthcare practitioners 
to inquire about CAM use when treating health conditions, particularly among lesbians.  Future 
studies are needed to determine how lesbians use CAM differently than heterosexual women, 
their reasons for use across time, and how their use of CAM impacts their health.  Two 
suggestions would be to more thoroughly examine how specific lesbian health barriers affect 
CAM use and to determine if lesbians use CAM more often in conjunction with or in place of 
conventional medicine than their heterosexual counterparts.  
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3.8 PAPER 1 TABLES 
Table 1.  Demographic and Health Characteristics and Unadjusted Odds Ratios of Lifetime History of 
Complementary and Alternative Medicine Use Among Lesbian and Heterosexual Women Enrolled in the 
ESTHER Project, Pittsburgh, PA, 2003-2006 
 
 
VARIABLE EVER USED (N=878)  
 NO (N, %) YES (N, %) OR (95% CI)* P 
Sexual Orientation 
 (N=878) 
Heterosexual 
Lesbian 
 
 
237 (59.3) 
204 (42.7)
 
163 (40.8) 
274 (57.3)
 
 
Baseline 
1.95 (1.49, 2.56) 
<0.0001
Age (N=878)                         
                                  35-39 
                           40-44 
                              45-49 
                                50-54 
                              55-65 
 
69 (54.8) 
118 (57.8)
103 (47.8) 
66 (42.3) 
85 (48.3)
 
 57 (45.2) 
   86 (42.2) 
113 (52.3) 
   90 (57.7) 
   91 (51.7) 
 
Baseline 
0.88 (0.56, 1.38) 
1.33 (0.86, 2.06) 
1.65 (1.03, 2.65) 
1.30 (0.82, 2.05) 
0.034
Race (N=878) 
 Caucasian 
African American 
 
389 (48.1) 
52 (74.3)
 
419 (51.9) 
   18 (25.7)
 
Baseline 
0.32 (0.19, 0.56) 
<0.0001
Education  (N=878) 
                         HS or Less 
Some College 
Bachelors 
Graduate 
 
73 (78.5) 
124 (58.5) 
100 (46.1) 
144 (40.5)
 
 20 (21.5) 
   88 (41.5) 
 117 (53.9) 
 212 (59.6)
 
Baseline 
2.59 (1.47, 4.56) 
4.27 (2.43,7.49) 
5.37 (3.14,9.20) 
<0.0001
Household Income  
(N=862) 
<  $25K 
        $25K -39K 
    $40-59K 
    $60K-75K 
> $75K 
 
 
67 (54.0) 
71 (48.6) 
105 (55.0)
44 (39.6) 
143 (49.3)
 
57 (46.0) 
  75 (51.4) 
  86 (45.0) 
  67 (60.4) 
147 (50.7) 
 
 
Baseline 
1.24 (0.77, 2.01) 
0.96 (0.61, 1.52) 
1.79 (1.07, 3.01) 
1.21 (0.79, 1.84)  
0.110
Self-Reported Health 
Status (N=878) 
Excellent 
Good 
Poor 
 
245 (50.3) 
150 (49.7) 
46 (51.7)
 
 
242 (49.7) 
   152 (50.3) 
   43 (48.3) 
 
 
Baseline 
1.03 (0.77, 1.37) 
0.95 (0.60, 1.49)  
0.944
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Table 1.  Continued 
VARIABLE EVER USED (N=878)  
 NO (N, %) YES (N, %) OR (95% CI)* P 
Last Routine Doctor’s 
Visit (N= 878) 
< 1 Year Ago 
>1 to 2 Years Ago 
> 2 Years or Don’t Know 
 
 
332 (51.5) 
62 (46.3) 
47 (47.5)
 
 
313 (48.5) 
  72 (53.7) 
  52 (52.5)
 
 
Baseline 
1.23 (0.85, 1.79) 
1.17 (0.77, 1.79)  
0.464
Have Provider of Usual 
Care?  (N=877)                    
                                      No  
Yes 
 
 
99 (61.9) 
341 (47.6)
 
 
61 (38.1) 
376 (52.4)
 
 
Baseline 
1.79 (1.26, 2.54) 
0.001
Perceived Discriminated 
in a Healthcare 
Establishment  (N=878) 
No 
Yes 
 
 
 
405 (53.6) 
36 (29.3)
 
 
 
350 (46.4) 
   87 (70.7) 
 
 
 
Baseline 
2.80 (1.85, 4.23)  
<0.0001
Health Insurance  
Coverage  (N=876) 
Uninsured 
Insured 
 
36 (52.9) 
405 (50.1)
 
 
  32 (47.1) 
403 (49.9) 
 
 
Baseline 
1.12 (0.68, 1.84)  
0.656
Residence (N=878) 
Large City 
Not Large City 
297 (41.7)
144 (55.7)
 
201 (58.3) 
236 (44.3) 
 
Baseline 
0.57 (0.43, 0.75) 
<0.0001
Spirituality (N=823) 
Somewhat or Not at all 
Spiritual 
Very Spiritual 
 
176 (54.3) 
154 (52.0) 
76 (37.4)
 
148 (45.7) 
142 (48.0) 
127 (62.6) 
 
Baseline 
1.10 (0.80, 1.50) 
1.99 (1.39, 2.84)  
<0.001
Diagnosed with:      
Heart Related Condition 
(N=875) 
No 
Yes 
 
 
240 (52.2) 
200 (48.2)
 
 
220 (47.8) 
215 (51.8) 
 
 
Baseline 
1.17 (0.90, 1.53)  
0.240
Cancer  (N=863) 
No 
Yes 
 
339 (49.8) 
30 (48.4) 
 
402 (50.2) 
  32 (51.6) 
 
Baseline 
1.06 (0.63, 1.78)  
0.829
Autoimmune Disorder 
(N=876) 
No 
Yes 
 
 
278 (52.9) 
162 (46.3)
 
 
248 (47.2) 
188 (53.7) 
 
 
Baseline 
1.30 (0.99, 1.71)  
0.057
Respiratory Disorder 
 (N=875) 
No 
Yes 
 
 
373 (52.0) 
65 (41.4)
 
 
345 (48.1) 
  92 (58.6) 
 
 
Baseline 
1.53 (1.08, 2.17)  
0.017
 
 
 
 28 
Table 1.  Continued 
VARIABLE EVER USED (N=878)  
 NO (N, %) YES (N, %) OR (95% CI)* P 
Mental Health Related 
Condition (N=876) 
No 
Yes 
 
 
270 (57.5) 
170 (41.9)
 
 
220 (42.6) 
236 (58.1) 
 
 
Baseline 
1.87 (1.43, 2.45) 
<0.0001
HIVAIDS  (N=876) 
No 
Yes 
434 (50.2) 
7 (63.6)
 
431 (49.8) 
     4 (36.4)
 
Baseline 
0.58 (0.17, 1.98)  
0.381
Ulcers  (N=875) 
No 
Yes 
 
421 (51.1) 
17 (33.3)
 
403 (48.9) 
   34 (66.7) 
 
Baseline 
2.09 (1.15, 3.80)  
0.016
*CI (Confidence Interval); OR (Odds Ratio) 
 
Table 2.  Demographic and Health Characteristics and Unadjusted Odds Ratios of Complementary and 
Alternative Medicine Use in the Past 12 Months Among Lesbian and Heterosexual Women Enrolled in the 
ESTHER Project, Pittsburgh, PA, 2003-2006 
 
VARIABLE CAM USE IN PAST 12 
MONTHS (N=877) 
  
 NO (N, %) YES (N, %) OR (95% CI) P 
Sexual Orientation 
 (N=877) 
Heterosexual 
Lesbian 
 
 
255 (63.8) 
250 (52.4)
 
 
145 (36.3) 
227 (47.6)
 
 
Baseline 
1.60 (1.22, 2.10) 
<0.001
Age (N=877)                         
                                  35-39 
                           40-44 
                              45-49 
                                50-54 
                              55-65 
 
76 (60.3) 
123 (60.6) 
127 (58.8) 
87 (55.77) 
92 (52.3)
   50 (39.7) 
   80 (39.4) 
   89 (41.2) 
   69 (44.2) 
   84 (47.7) 
 
Baseline 
0.99 (0.63, 1.56) 
1.07 (0.68, 1.67) 
1.21 (0.75, 1.94) 
1.38 (0.87, 2.21) 
0.479
Race (N=877) 
 Caucasian 
African American 
 
444 (55.0) 
61 (87.1)
 
363 (45.0) 
     9 (12.9)
 
Baseline  
0.18 (0.09, 0.37) 
<0.0001
Education (N=877) 
                         HS or Less 
Some College 
Bachelors 
Graduate 
 
77 (82.8) 
145 (68.4) 
115 (53.0) 
168 (47.3)
 
   16 (17.2) 
   67 (31.6) 
 102 (47.0) 
 187 (52.7)
 
Baseline 
2.22 (1.21, 4.10) 
4.27 (2.34, 7.78) 
5.36 (3.01, 9.54) 
<0.0001
Household Income  
(N=861) 
<  $25K 
        $25K -39K 
    $40-59K 
    $60K-75K 
> $75K 
 
 
76 (61.3) 
78 (53.4) 
116 (60.7) 
56 (50.5) 
167 (57.8)
  48 (38.7) 
  68 (46.6) 
  75 (39.3) 
  55 (49.6) 
122 (42.2) 
 
 
Baseline 
1.38 (0.85, 2.24) 
1.02 (0.64, 1.63) 
1.56 (0.93, 2.61) 
1.16 (0.75, 1.78)  
0.313
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Table 2.  Continued 
VARIABLE CAM USE IN PAST 12 
MONTHS (N=877) 
  
 NO (N, %) YES (N, %) OR (95% CI) P 
Self-Reported Health 
Status (N=877) 
Excellent 
Good 
Poor 
 
 
274 (56.4) 
178 (58.9) 
53 (59.6)
 
 
212 (43.6) 
124 (41.1) 
36 (40.5) 
 
 
Baseline 
0.90 (0.67, 1.21) 
0.88 (0.55, 1.39)  
0.720
Last Routine Doctor’s 
Visit (N= 877  ) 
< 1 Year Ago 
>1 to 2 Years Ago 
> 2 Years or Don’t Know 
 
 
367 (57.0) 
75 (56.0) 
63 (63.6)
 
 
277 (43.0) 
  59 (44.0) 
  36 (36.4)
 
 
Baseline 
1.04 (0.72, 1.52) 
0.76 (0.49, 1.17)  
0.423
Have Provider of Usual 
Care? (N=876)                     
                                      No  
Yes 
 
 
112 (22.2) 
392 (54.7)
 
 
47 (29.6) 
325 (45.3)
 
 
Baseline 
1.98 (1.36, 2.86) 
<0.001
Perceived Discriminated 
in a Healthcare 
Establishment (N=877) 
No 
Yes 
 
 
 
450 (59.6) 
55 (45.1)
 
 
 
305 (40.4) 
   67 (54.9) 
 
 
 
Baseline 
1.80  (1.22, 2.64) 
0.003
Health Insurance  
Coverage (N=875) 
Uninsured 
Insured 
 
 
43 (63.2) 
462 (57.3)
 
 
  25 (36.8) 
345 (42.8) 
 
 
Baseline 
1.28 (0.77, 2.14)  
0.338
Residence  
(N=877) 
Large City 
Not Large City 
 
 
169 (49.1) 
336 (63.0)
 
 
175 (50.9) 
197 (37.0)
 
 
Baseline 
0.57 (0.43, 0.75) 
<0.0001
Spirituality  
(N=823) 
Somewhat or Not at all 
Spiritual 
Very Spiritual 
 
 
207 (63.9) 
172 (58.1) 
86 (42.4)
117 (36.1) 
124 (41.9) 
117 (57.6) 
 
 
Baseline 
 1.28 (0.92, 1.76) 
2.41 (1.68, 3.45)  
<0.0001
Currently Depressed  
( N=874) 
No 
Yes 
 
 
406 (57.8) 
33 (62.3)
297 (42.3) 
20 (37.7)
 
 
Baseline 
0.83 (1.05, 3.28) 
0.522
Diagnosed with:      
Heart Related Condition 
( N=874) 
No 
Yes 
 
 
274 (59.6) 
229 (55.3)
 
 
186 (40.4) 
185 (44.7) 
 
 
Baseline 
1.19 (0.91, 1.56)  
0.204
Cancer  (N=862) 
No 
Yes 
 
459 (57.4) 
33 (53.2)
 
341 (42.6) 
  29 (46.8) 
 
Baseline 
1.18 (0.71, 1.99)  
0.525
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Table 2.  Continued 
VARIABLE CAM USE IN PAST 12 
MONTHS (N=877) 
  
 NO (N, %) YES (N, %) OR (95% CI) P 
Autoimmune Disorder 
(N=875) 
No 
Yes 
 
 
315 (60.0) 
189 (54.0)
 
 
210 (40.0) 
161 (46.0) 
 
 
Baseline 
1.28 (0.97, 1.68)  
0.079
Respiratory Disorder 
 (N=874) 
No 
Yes 
 
 
415 (57.9) 
87 (55.4)
 
 
302 (42.1) 
  70 (44.6) 
 
 
Baseline 
1.11 (0.78, 1.57) 
0.572
Mental Health Related 
Condition (N=875) 
No 
Yes 
 
 
297 (63.2) 
207 (51.1)
 
 
173 (36.8) 
198 (48.9) 
 
 
Baseline 
1.64 (1.25, 2.15)  
<0.001
HIVAIDS  (N=875) 
No 
Yes 
 
497 (57.5) 
8 (72.7)
 
367 (41.9) 
     3 (27.3) 
 
Baseline 
0.51  (0.13, 1.93)  
0.320
Ulcers  ( N=875) 
No 
Yes 
 
481 (58.4) 
22 (43.1)
 
342 (41.6) 
   29 (56.9) 
 
Baseline 
1.85 (1.05, 3.28)  
0.034
*CI (Confidence Interval); OR (Odds Ratio) 
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Table 3.  Comparison of Complementary and Alternative Medicine (CAM) Modality Rates Among Lesbian 
and Heterosexual Women Who Used CAM in the Past 12 Months, ESTHER Project, Pittsburgh, PA, 2003-
2006 
 
Alternative Service 
 
Total  
(N=372) 
N (%) 
Lesbian  
(N=227)  
N (%) 
Heterosexual 
(N=145) 
N (%) 
P 
Acupuncture    27 (7.3)   20 (8.8)   7 (4.9) 0.159  
Aromatherapy    31 (8.4)   14 (6.2) 17 (11.9) 0.053  
Biofeedback     4 (1.1)     4 (1.8)   0 (0) 0.162  
Herbal Medicines   89 (24.1)    55 (24.2) 34 (23.8) 0.921  
Homeopathy      0 (0)     0   0 NA  
Hypnosis   13 (3.5)     9 (4.0)   4 (2.8) 0.553  
Massage 264 (71.4) 168 (74.0) 96 (67.1) 0.154  
Meditate   94 (25.4)   56 (24.2) 39 (27.3) 0.513  
Reiki   45 (12.2)   31 (13.7) 14 (9.8) 0.268  
Relaxation    75 (20.3)   39 (17.2) 36 (25.2) 0.063  
Healing Touch   25 (6.8)   18 (7.9)   7 (4.9) 0.258  
Yoga 118 (31.9)   59 (26.0) 59 (41.3) 0.002 
Other    63 (17.0)   36 (15.9) 27 (18.9) 0.451  
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Table 4.  Adjusted Odds Ratios of Lifetime History and Past 12 Month Complementary and Alternative 
Medicine Use Among Lesbian and Heterosexual Women, ESTHER Project, Pittsburgh, PA, 2003-2006 
 
VARIABLE EVER USED USED PAST 12 MONTHS 
 AOR (95% CI)* P AOR (95% CI) P 
Age                                                          
                                                    35-39 
                           40-44 
                              45-49 
                                50-54 
                              55-65 
 
Baseline 
0.92 (0.55, 1.52) 
1.67 (1.01, 2.77) 
1.38 (0.81, 2.37) 
1.41 (0.83, 2.38)
0.062  
Baseline 
1.16 (0.69, 1.93) 
1.28 (0.77, 2.13) 
1.03 (0.60, 1.78) 
1.47 (0.87, 2.48)
0.557
Sexual Orientation         
Heterosexual  
Lesbian  
 
Baseline 
1.68 (1.23, 2.28)
0.001  
Baseline 
1.44 (1.06, 1.97)
0.021
Race           
                                           Caucasian 
                               African American  
Baseline 
0.31  (0.16, 0.59)
<0.001 Baseline 
0.17 (0.08, 0.38)  
<0.0001
Education                         HS or Less  
Some College  
Bachelors  
Graduate  
Baseline 
2.21 (1.22, 4.39) 
3.77 (2.00, 7.13) 
4.16 (2.26, 7.64)  
<0.0001 Baseline 
1.71 (0.88, 3.33) 
3.16 (1.63, 6.11) 
3.54 (1.89, 6.64)  
<0.0001
Perceived Discriminated in a 
Healthcare Establishment   
                                                         No 
                 Yes  
 
 
Baseline 
2.48 (1.53, 4.03)
<0.001  
 
Baseline 
1.63 (1.03, 2.57)
0.036 
Residence                          Large City  
Not Large City  
Baseline 
0.63 (0.46, 0.86)
0.004 Baseline 
0.62 (0.45, 0.84)
0.002
Spirituality 
Somewhat or Not at all 
Spiritual 
Very Spiritual  
 
Baseline 
1.03 (0.73, 1.45) 
2.27 (1.50, 3.44)
<0.001  
Baseline 
1.21 (0.86, 1.72) 
2.74 (1.83, 4.10)
<0.0001
Have Provider of Usual Care?    No  
Yes  
______ ______ Baseline 
1.81 (1.89, 2.76)  
0.005
Mental Health Related 
Condition                                        No  
Yes 
 
Baseline 
1.48 (1.09, 2.02)
0.013  
Baseline 
1.48 (1.09, 2.02)
0.043 
* CI (Confidence Interval); AOR (Adjusted Odds Ratio)  
CAM use ever adjusted for: Age, race, sexual orientation,   reported discrimination in a healthcare 
establishment, residence, spirituality, and previous mental health diagnosis 
Past 12 Month CAM adjusted for:  Age, race, sexual orientation, reported discrimination in a healthcare 
establishment, residence, spirituality, have provider of usual care, and previous mental health diagnosis 
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4.1 ABSTRACT 
Objectives:  Prior studies indicate that women who have experienced childhood sexual abuse 
(CSA) are at greater risk for obesity.  Published research shows that lesbians have higher rates of 
both self-reported sexual abuse (SA) and adult overweight/obesity when compared to 
heterosexual women; however, this association has not been fully explored.  Our aim was to 
investigate the association between SA history and current adulthood obesity among women who 
participated in the ESTHER (Epidemiologic STudy of HEalth Risk in Women) Project.  The 
ESTHER Project (2003-2006) included 1084 women who were 35 years of age and older, half 
self-identified as lesbian (n=504).  Methods:  Three self-reported sexual abuse measures were 
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used. CSA was assessed by asking respondents whether they were sexually abused by a family 
member or non-family member prior to age 18.  Adult sexual abuse (ASA) asked about forced 
sexual activity after age 18.  Obesity was defined as having a BMI > 30 and differences between 
obese and non-obese women were explored.  Chi squared and Fisher’s exact tests, and univariate 
and multiple logistic regression analyses were implemented for analytical purposes.   
Results:  Logistic regression analysis adjusting for potential confounders revealed that having 
less education than a bachelors’ degree, a lower household income, African American race, 
lesbian sexual orientation, reported CSA by a family member, and history of a mental health 
diagnosis were associated with current obesity in adulthood.  
Conclusions:  Physicians and health programs need to recognize that a lesbian sexual orientation 
and having a history of childhood sexual abuse perpetrated by a family member are associated 
with a heavy body mass.   
4.2 INTRODUCTION 
Adulthood obesity rates in the United States increased from 13% to 32% between the 1960s and 
200465 and accounted for approximately 9.1% ($78.5 billion) of medical expenditures in 1998.66  
Obesity, the leading cause of preventable death, is associated with health conditions such as 
hypertension, cardiovascular disease, diabetes mellitus, and some cancers.67 68  The etiology of 
obesity is complex and multidimensional involving genetic, environmental, and individual 
factors, which make obesity prevention, treatment, and weight maintenance programs complex.  
A better understanding of the risk factors leading to obesity is greatly needed.  Over the past 
decade scientists have been trying to better understand the psychosocial components that 
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contribute to obesity, and have found that obese individuals are more likely to have a history of 
depression, anxiety, suicidal thoughts and ideation, and disordered eating.69  Mounting research 
has been published examining the relationship between sexual abuse (SA) and obesity among 
adult women. 69-73  The majority of findings concur that a small, positively correlated association 
between childhood sexual abuse (CSA) and obesity exists.69  There is a lack of published studies 
that specifically examine the relationship between adult sexual abuse (ASA) and adulthood 
obesity.   
Some researchers believe that obesity may be used by female SA survivors as an adaptive 
strategy to avoid sex in relationships and/or to deter potential sexual predators.  They 
hypothesize that a higher body weight is maintained because the SA survivor does not want to be 
viewed as a sexual object.69  Following this theory researchers have found that some women with 
SA histories have a “barrier weight” where weight is lost or gained to become less attractive 
and/or to have a different sized body than the one they had at the onset or time of sexual 
victimization.  Some women with SA histories who begin to lose weight experience post-
traumatic stress disorder symptoms as they approach the weight they were when they were 
sexually abused, which obviously can interfere with weight loss plans.69  If the theory that 
obesity is used as an adaptive strategy by SA survivors is correct, obese women with SA 
histories may be less motivated to lose weight which could lead either to reduced weight loss 
attempts or unsuccessful weight loss.69 74   
A number of research studies have found that lesbians have higher rates of obesity 14 75 76  
and report higher rates of CSA 77-79 and ASA 77 80 when compared to heterosexual women.  Only 
one published study exists that examines the association of adulthood obesity and CSA among 
lesbians.   In a community sample of lesbians Aaron and colleagues found that CSA was 
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significantly associated with body weight, with those who experienced CSA being more likely 
than those who did not to be obese (BMI 30.0 to 39.9) or severely obese (BMI >40)after 
adjusting for age, race/ethnicity, and education.71   A limitation of their study is that they did not 
have a heterosexual comparison group. 
To our knowledge there are no published reports that directly examine the association 
between CSA, ASA, and current adulthood obesity in a large population of lesbian and 
heterosexual women. This study’s primary objective was to explore demographic and mental 
health risk factor differences in adulthood obesity among lesbian and heterosexual women 
enrolled in the Epidemiologic STudy of HEalth Risk (ESTHER) Project.  Specific aims were to: 
(1) determine differences between sexual orientation and current adulthood obesity (2) examine 
potential differences between SA history and current adulthood obesity and (3) to determine 
correlates of current adulthood obesity adjusting for sexual orientation, SA history, and other 
potential covariates.    
4.2.1 Study Design and Data Collection 
The following analysis was based on information collected among heterosexual (N=581) 
and lesbian (N=503) women enrolled in the ESTHER Project at the University of Pittsburgh 
between 2003 and 2006.  The purpose of the ESTHER Project was to conduct a cross-sectional 
study analyzing heart disease risk factors among women living in the Pittsburgh, Pennsylvania 
area.  Participants were recruited through various methods known to help recruit hard-to-reach 
populations such as local newspaper and radio advertisements; health events; lesbian, gay, 
bisexual, and transgender (LGBT) events and social engagements; and The University of 
Pittsburgh broadcast phone-message system.  Recruitment/screening calls were performed by 
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trained research staff who scheduled two clinic visits at the University of Pittsburgh for those 
who met the study eligibility criteria.  At the first visit participants completed study 
questionnaires, physical activity and medical history interviews, and a fasting venipuncture.  At 
the second clinic visit participants reviewed their completed food diaries with research staff and 
underwent a  Dual Energy X-ray Absorptiometry (DXA) scan of the hip, spine, and whole body 
Participants were reimbursed $50 for their time and participation.  All information used in this 
analysis was obtained from the recruitment call forms, study questionnaires, and clinical 
measurements.  Study instruments and protocol were approved by the University of Pittsburgh’s 
Institutional Review Board (IRB).  Signed consent forms were obtained from each participant.  
4.2.2 Study Population and Data Reduction 
Women met eligibility criteria if they self-identified as a lesbian or heterosexual woman, 
were at least 35 of age, and had no previous history of heart disease (angina, heart attack, or 
stroke).   The final sample included women who were less than age 65 to solve the problem of 
disproportionate numbers of older heterosexuals compared to older lesbian women.  African 
American heterosexuals were randomly selected in the same proportion as African American 
lesbians recruited into the study because of disproportionately low accrual rates of African 
American lesbians.   Data from 879 women were used for the present analysis: 38 African 
American lesbians, 441 Caucasian lesbians, 32 African American heterosexuals, and 368 
Caucasian heterosexuals.   
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4.2.3 Measures 
Dependent Variable 
Obesity:  The National Heart Lung and Blood Institute (NHLBI)-defined cutoff categories were 
used to measure body mass index (BMI): <18.5 (underweight), 18.5 to 24.9 (normal), 25.0 to 
29.9 (overweight), 30.0 to 34.9 (mildly obese); 35.0 to 39.9 (severely obese) and > 40 (morbidly 
obese).  The World Health Organization (WHO)-defined cutoff points are identical to the 
NHLBI guidelines except that the three obesity categories are given different titles: Obesity 
Class 1, Obesity Class 2 and Obesity Class 3.67  For the purposes of our analysis we compared 
women who were obese to those who were not obese and defined obesity as having a BMI >30.   
BMI was calculated as weight in kilograms divided by the square of height in meters [weight 
(kg)/height (m)2].  The height and weight measurements used to calculate BMI were taken at the 
first clinic visit. 
Independent Variables 
Demographics:  Age, race, and sexual orientation were obtained from the recruitment interview.  
Household income, years of education, and current relationship status were obtained from the 
demographics questionnaire distributed at the first clinic visit. 
Sexual Orientation:  Sexual orientation was based on self-reported sexual orientation, sexual 
behavior, and romantic attraction at time of screening.  Participants were classified as either 
being heterosexual or lesbian.  Heterosexuals were defined as those who self-identified as 
heterosexual or straight and only had male sexual partners since the age of 18.  Lesbians were 
defined as those who did not identify as heterosexual or straight and whose emotional, physical, 
and romantic attractions within the past 5 years have been towards only or primarily women or 
whose relationships within the past 5 years have been towards only or primarily women. 
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Sexual Abuse:  SA was assessed by self report through three measures in a written 
questionnaire.   CSA was assessed by asking respondents whether they were sexually abused by 
a family member or non-family member prior to the age of 18 while ASA asked about forced, 
unwanted sexual activity after age 18.   From these sexual abuse history measures a fourth SA 
measure was created, lifetime history of SA (SA-Ever), based on reported SA before and after 
age 18. 
Past History of Mental Health Diagnoses:  Respondents were asked if they had ever been 
diagnosed by a medical professional with depression, anxiety, and/or an eating disorder.  For the 
purpose of this analysis, these factors were combined into one dichotomous variable of ever 
having been diagnosed with a mental health disorder. 
Current CESD Depression Score:  The 10-item Center for Epidemiologic Studies Depression 
Scale (CES-D 10) was used to assess current depression at the time of participants’ first clinic 
visit.  A score >10 suggests a clinically significant level of psychological distress.53 54  
4.2.4 Statistical Analysis 
Categorical variables were analyzed using chi squared tests and continuous variables were 
examined using t-tests. The factors used in regression analysis held p-values of <0.25 in the 
univariate analysis.  Collinearity tests were performed and those that had a VIF (Variance 
Inflation Factor) >10 were removed.  Multivariate logistic regression models were used to 
determine the correlates of obesity (BMI >30).  Statistical significance for multiple logistic 
regression models was defined as p<0.05.  Statistically significant interactions were considered 
in the final models.  The Hosmer-Lemeshow statistic was used to evaluate the overall model fit.  
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All statistical analyses were performed using the SAS system for Windows, version 9.2 (SAS 
Institute, Cary, North Carolina). 
4.3 RESULTS 
Overall the sample was highly educated, 65.3% (N=574) having completed a bachelors degree or 
higher and almost half (46.5%, N=320) had a household income of $60K or higher (Table 5).  
The mean age of the sample was 47.6 (+ 7.3) years.  The majority of women were Caucasian 
(92.0%, N= 809) with only 8.0% (N=70) being African American.  Approximately half the 
sample were lesbians (N=479, 54.5%) and the majority of women were in committed 
relationships (70.7%, N=621).  According to NHLBI BMI standard-cutoff points, 35.2% 
(N=310) of women in the ESTHER Project were obese (BMI>30) at the time of their first clinic 
visit.  Approximately 50.3% of women in our sample reported being sexually abused in their 
lifetime, 23.4% reported sexual abuse under the age of 18 by a family member,  23.5% reported 
sexual abuse under the age of 18 by a non-family member, and 34.4% reported forced, unwanted 
sex after the age of 18.    
4.3.1 Obesity Status among ESTHER Participants 
Univariate Analysis 
Univariate analyses (Table 6) revealed that women who were obese (BMI >30) did not differ by 
age or relationship status compared to non-obese women.  Obese women, however, were more 
likely to be lesbian (Odds Ratio (OR)=1.57 [95% Confidence Interval [CI]: 1.81, 2.08]), African 
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American (OR=4.56, [2.69, 7.71]), have a lower household income (p<.0001), and have fewer 
years of education (P<.0001) than their non-obese counterparts.  All SA variables were 
univariately associated with obesity:  SA-Ever (1.43, [CI: 1.07, 1.92]), CSA by a family member 
(2.06, [1.48, 2.86]), CSA by a non-family member (1.53 [1.10, 2.13]), and ASA (1.34, (1.03, 
1.87)].  Obese women were also more likely than non-obese women to be currently depressed 
(OR=2.32 [1.32, 4.07]) and have higher rates of ever being diagnosed with a mental illness 
(OR=1.63 [1.23, 2.16]).  
Multivariate Analyses 
A lesbian sexual orientation remained a predictor of obesity in bivariate analysis, when 
also adjusting for each SA measure separately; however, not all SA measures were significantly 
associated with obesity (Table 7).  Only reported CSA by a family member (OR=1.94 [CI: 1.39, 
2.71]) and reported CSA by a non-family member (OR=1.41 [CI: 1.01, 1.98]) were associated 
with being obese. ASA and SA-Ever, were not significantly related to obesity when also 
adjusting for sexual orientation. 
Four multivariate logistic regression models (Tables 8 and 9) were performed to 
determine if sexual orientation and SA variables were associated with obesity after adjusting for 
demographic and mental health variables.  In all models, being African American, lesbian sexual 
orientation, education less than a bachelors’ degree, and a previous mental health diagnosis were 
significantly associated with obesity.  Likewise, each model revealed that women having a 
household income greater than $75K were less likely to be currently obese.  Current relationship 
status was not significantly associated with obesity in any model.  CSA by a family member was 
the only significant SA predictor of obesity (Adjusted Odds Ratio (AOR)=1.56 [CI: 1.09, 2.24]).  
Age was not a significant predictor of obesity in any of the logistic regression models; however, 
 42 
it was forced into the models because it is a known predictor of obesity.  For each model, the 
Hosmer-Lemeshow Goodness of Fit Test showed that main effects model was a good fit for the 
data.  
4.4 DISCUSSION 
The purpose of this analysis was to investigate risk factors of obesity in a large community-based 
sample of lesbian and heterosexual women in the Pittsburgh, Pennsylvania area.  Specific aims 
were to interpret differences in current adulthood obesity status by sexual orientation and SA 
history and to determine if sexual orientation and history of sexual abuse were associated with 
obesity after adjusting for specific demographic and mental health variables.  Demographic and 
mental health factors considered for analysis included: age, race, sexual orientation, education, 
household income, current relationship status, history of ever having a mental health diagnosis, 
and history of sexual abuse.   
We found that a lesbian sexual orientation was independently related to adulthood obesity 
after accounting for selected covariates.  These results are consistent with the current literature 
concluding that lesbians have higher rates of obesity than heterosexual women. 13 14 22-24  
Although all SA measures were univariately associated with obesity, bivariate analyses showed 
that only the two CSA measures were significantly related to obesity.  CSA by a family member 
was strongly significant (p<0.001) while reported CSA by a non-family member was marginally 
significant (p=.046).   After adjusting for all other demographic and mental health variables, only 
CSA by a family member was independently associated with obesity (p=0.015).  The 
relationship between obesity and CSA by a non-family member was not significant.  This finding 
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is similar to published studies which have found an association between obesity and CSA in 
groups of women. 69 71 73 74  This study was able to add to obesity-related lesbian health research 
literature by suggesting that the relationship of the perpetrator to the CSA victim could help 
explain the association between CSA and adulthood obesity.  
The non-significant association between adulthood obesity and ASA may explain the 
lack of published literature on this topic.  It is extremely important to clarify the (1) age sexual 
abuse occurred and (2) relationship of the sexual perpetrator to the SA survivor. Our results 
indicate that that SA-Ever may be a non-significant predictor of obesity because reported ASA 
minimized the association between obesity and SA-Ever in our population. 
As expected, these results also resembled the outcome of other studies in that race, 65 67 81 
socio-economic status (years of education and household income), 65 82 and mental health history 
74 are independently associated with obesity.  This analysis found that women who reported a 
household income of $75K or greater or had a graduate degree were less likely to be obese.   
African American women and women who reported a history of a mental health diagnosis were 
more likely to be obese than Caucasian women or women who were never given a mental health 
diagnosis.  Studies have produced mixed results on the association between obesity and 
relationship/marital status.83 84  This analysis concluded that relationship status did not predict a 
significant association with obesity status.  Although age is a known risk factor for obesity 65 we 
did not find an association, which may be explained by the narrow age-range of our sample (35 
to 65).   
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4.5 LIMITATIONS 
Comparing the relationship of sexual abuse history, lesbian sexual orientation, and current 
adulthood obesity across studies is complex; largely because of varying definitions of sexual 
abuse and lesbian sexual orientation.  This also applies to the present analysis.  Our conclusions 
are limited to the general definitions of SA that were used, specifically that severity or duration 
of sexual victimization was not measured.  In addition, it is unknown how each woman defined 
sexual abuse: attempted SA, verbal SA, physical SA or a combination of these acts.  Despite the 
lack of specific details of our SA measures it can be argued that if a woman reported SA in her 
lifetime, no matter the severity or duration of SA, her reported SA events(s) may have some 
impact on her mental and physical health.  Another bias, common across SA studies, is that not 
all women who have experienced SA may have felt comfortable reporting it which means the 
prevalence of SA may actually be higher in this sample.  Being silent about SA is not 
uncommon.  In a study of community sample of lesbians conducted by Roberts et al., 52.1% of 
those experiencing SA indicated that they had never told anyone about their SA experience.85    
 Several other important limitations should be considered when interpreting our findings. 
Because this is a cross-sectional study, findings only represent data collected at one point in 
time.  Longitudinal studies are needed to further explore the association between demographic 
and mental health factors and obesity over time.  In addition, it is important to acknowledge that 
lesbians represented in this analysis are “out” to some degree; results describe women 
comfortable with reporting their sexual orientation.  Conclusions are also limited to lesbian and 
heterosexual women; therefore, do not represent women with questioning or bisexual sexual 
identities.  This sample also mainly represents older adult women who are well educated, largely 
middle-class, and primarily Caucasian.   
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4.6 CONCLUSIONS 
Our findings help fill the research gap in published literature that reports on the relationship of 
sexual orientation, history of sexual abuse, and current adulthood obesity.  Importantly, we have 
found that sexual orientation and CSA perpetrated by a family member are both independently 
associated with current adulthood obesity after adjusting for other demographic and mental 
health factors.  Other predictors of obesity using multiple logistic regression were: African 
American race, education less than a graduate degree, household income less than $75K, and 
history of a mental health diagnosis (depression, anxiety, and eating disorders).   
From our analysis it is clear that a lesbian sexual orientation is independently associated 
with obesity; however, the effects of SA on current adulthood obesity are less understood.  In 
univariate and bivariate analyses, many of our SA measures were significantly associated with 
obesity; however, this was not the case after adjusting for other covariates.  Although lifetime 
history of SA, CSA by a non-family member, and ASA were not significantly associated with 
current adulthood in obesity after adjusting for other factors, an association may still exist, 
especially for those who may have experienced SA revictimization.  These non-significant 
outcomes may be partly the result of our research definitions of SA.  Therefore, further 
investigation is needed examining how obesity may be influenced by SA history among lesbian 
and heterosexual women.      
Our study findings suggest that there is a need for physicians and weight programs to 
consider how a lesbian sexual orientation and/or a history of SA may impact weight gain and 
loss.  This is especially the case for lesbians and women with a history of CSA perpetrated by a 
family member.  Future research is needed to explore the specific needs of sexual minority 
women and women who have experienced SA.  Furthermore, a greater understanding of the 
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association between sexual orientation, sexual abuse history, and obesity is needed among 
subpopulations of women (younger women, racial/ethnic minorities, and lower socio-economic 
groups).  
4.7 PAPER 2 TABLES 
Table 5.  Rates of Demographic and Mental Health Factors of Lesbian and Heterosexual Women Enrolled in 
the ESTHER Project, Pittsburgh, PA, 2003-2006 
 
Variable Total Population 
(N=879) 
N (%) 
Age (N=879) 
34-39
40-44
45-49
50-64
55-65
  
126 (14.3) 
204 (23.2) 
216 (24.6) 
156 (17.8) 
177 (20.1) 
Race (N=879) 
Caucasian
African American
 
809 (92.0) 
  70  (8.0) 
Sexual Orientation (N=879) 
Heterosexual
Lesbian
 
400 (45.5) 
479 (54.5) 
Education (N=879) 
HS or Less
Some College
Bachelors
Graduate
 
  93 (10.6) 
212 (24.1) 
218 (24.8) 
356 (40.5) 
Education (N=879) 
<BS
>BS
 
305 (34.7) 
574 (65.3) 
Household Income  (N= 863 ) 
<$25
$25K-$39K
$40K-$59K
$60K-$74K
$75+
 
125 (14.5) 
146 (16.9) 
191 (22.1) 
111 (12.9) 
209 (33.6) 
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Table 5.  Continued 
    
Variable Total Population 
(N=879) 
N (%)
In a Committed Relationship  
 (N= 878 ) 
Yes
No
 
 
621 (70.7) 
257 (29.3) 
Previous Mental Health Diagnosis 
(Depression, Anxiety, Eating 
Disorder)  (N= 876) 
No
Yes
 
 
 
470 (53.7) 
406 (46.4) 
CESD Score – Currently Depressed 
(N=821) 
No
Yes
 
 
704 (93.0) 
  53 (7.0) 
SA Lifetime History of Sexual 
Abuse (Ever)   (N=821) 
No
Yes
 
 
408 (49.7) 
413 (50.3) 
CSA by a Family member  (N=822) 
No
Yes
 
630 (76.6) 
192 (23.4) 
CSA by a Non-Family Member 
(N=822) 
No
Yes
 
 
629 (76.5) 
193 (23.5) 
ASA (N=821 ) 
No
Yes
 
539 (65.7) 
282 (34.4) 
NHLBI Body Mass Index (N=879) 
Underweight (BMI  <18.5) 
Normal (BMI 18.5-24.9)
Overweight (BMI 25- 29.9)
Mildly Obese (BMI 30-34.9)
Severely Obese (BMI 35-40)
Morbidly Obese (BMI > 40)
 
   12 (1.4) 
303 (34.5) 
254 (28.9) 
153 (17.4)  
   86 (9.8) 
   71 (8.1) 
Currently Obese (N=879) 
Not Obese (BMI <30)
Obese (BMI >30)
 
569 (64.7) 
310 (35.3) 
Variable (N) Total  Mean (SD) 
Recruitment Age (N=879) 47.6 (7.3) 
CESD Depression Score (N=872) 6.3 (5.0) 
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Table 6.  Comparison and Unadjusted Odds Ratios of Demographic and Mental Health Factors by Current 
Adulthood Obesity Status Among Lesbian and Heterosexual Women Enrolled in the ESTHER Project, 
Pittsburgh, PA, 2003-2006 
 
VARIABLE BMI (KG/M2)   
 BMI <30 
(N=569) 
N (%) 
BMI > 30.0 
(N=310) 
N (%) 
UNADJUSTED 
OR,  (95% CI) 
P 
Age* 47.6 (7.4) 47.5 (7.3) 0.99 (0.98, 1.02) 0.840
Age   
34-39 
40-44 
45-49 
50-64 
55-65 
 
83 (65.9) 
131 (64.2) 
139 (64.4) 
96 (61.5) 
120 (67.8) 
 
43 (34.1) 
73 (35.8) 
77 (35.7) 
60 (38.5) 
57 (32.2) 
 
Baseline 
1.08 (0.68, 1.72)  
1.07 (0.67. 1.70)  
1.21 (0.74, 1.97)  
0.92 (0.57, 1.49)  
0.821 
Race   
Caucasian American 
African American 
 
547 (67.6) 
22 (31.4)
 
262 (32.4) 
48 (68.6)
 
Baseline 
4.56 (2.69, 7.71)  
<0.0001 
Sexual Orientation   
Heterosexual 
Lesbian 
 
281 (70.3) 
288 (60.1) 
 
119 (29.8) 
191 (39.9) 
 
Baseline 
1.57 (1.81, 2.08)  
0.002 
Education   
High School or Less 
Some college 
BA 
Graduate 
 
52 (55.9) 
108 (50.9) 
150 (68.8) 
259 (72.8) 
 
41 (44.1) 
104 (49.1) 
68 (31.2) 
97 (27.3) 
 
Baseline 
1.22 (0.75, 1.99)  
0.58 (0.35, 0.95)  
0.48 (0.30, 0.76)  
<0.0001 
Household Income 
<$25 
$25K-$39K 
$40K-$59K 
$60K-$74K 
$75+ 
 
65 (52.0) 
91 (62.3) 
118 (61.8) 
65 (58.6) 
222(76.6) 
 
60 (48.0) 
55 (37.7) 
73 (38.2) 
46 (41.4) 
68 (23.5) 
 
Baseline 
0.66 (0.40, 1.06)  
0.67 (0.43, 1.06)  
0.77 (0.46, 1.28)  
0.33 (0.21, 0.52)  
<0.0001 
In a Committed Relationship  
Yes 
No 
 
407 (65.5) 
162 (63.0) 
 
214 (34.5) 
95 (37.0) 
 
Baseline 
1.11 (0.82, 1.51)  
0.480 
Previous Mental Health 
Diagnosis (Depression, 
Anxiety, Eating Disorder)   
No 
Yes 
 
 
 
328 (69.8) 
238 (58.6) 
 
 
 
142 (30.2) 
168 (41.4) 
 
 
 
Baseline  
1.63 (1.23, 2.16)  
<.0.001 
CESD Score – Currently 
Depressed 
No 
Yes 
 
 
475 (67.5) 
25 (47.2)
 
 
229 (32.5) 
28 (52.8)
 
 
Baseline 
2.32 (1.32, 4.07)  
.003 
Lifetime History of Sexual 
Abuse (Ever) 
No 
Yes 
 
 
284 (69.6) 
124 (30.4)
 
 
254 (61.5) 
157 (38.5)
 
 
Baseline 
1.43 (1.07, 1.92)  
.015 
 
 
Table 6.  Continued 
CSA by a Family member   
No 
Yes 
 
438 (69.5) 
101 (52.6)
 
192 (30.5) 
91 (47.4)
 
Baseline 
2.06 (1.48, 2.86)  
<0.0001 
CSA by a Non-Family 
Member                                No 
Yes 
 
427 (67.9) 
112 (58.0)
 
202 (32.1) 
81 (42.0)
 
Baseline 
1.53 (1.10, 2.13)  
0.12 
ASA  
No 
Yes 
 
367 (68.1) 
171 (60.6)
 
172 (31.9) 
111 (39.4)
 
Baseline  
1.34 (1.03, 1.87)  
0.33 
* Mean (Standard Deviation) 
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Table 7.  Comparison and Adjusted Odds Ratios of Factors Related to Obesity by Sexual Orientation and Type of Sexual Abuse, ESTHER Project, 
Pittsburgh, PA, 2003-2006 
 
VARIABLE BMI (KG/M2) OR (L:H)  P OR  (ABUSED  
YES:NO) 
P 
 BMI <30 (%) 
(N=569) 
BMI >30 (%) 
(N=310) 
OR (95% CI)  OR (95% CI)  
 H L H L    
Lifetime History of Sexual 
Abuse (Ever) 
No 
Yes 
 
164 (61.4) 
103 (38.6)
 
120 (44.3) 
151 (55.7)
 
62 (55.9) 
49 (44.1)
 
62 (36.1) 
110 (64.0)
1.45 (1.08, 1.95) 0.015 1.34 (1.00, 1.80) 0.051
CSA by a Family member 
 
No 
Yes 
 
 
236 (88.4) 
31 (11.6)
 
 
202 (74.3) 
70 (25.7)
 
 
81 (73.0) 
30 (27.0)
 
 
111 (64.5) 
61 (35.5)
1.40 (1.04, 1.88) 0.028 1.94 (1.39, 2.71) <0.001
CSA by a Non-Family 
Member  
No 
Yes 
 
 
229 (85.8) 
38 (14.3)
 
 
198 (72.8) 
74 (27.2)
 
 
94 (84.7) 
17 (15.3)
 
 
108 (62.8) 
64 (37.2)
1.44 (1.07, 1.94) 0.017 1.41 (1.01, 1.98) 0.046
ASA 
 
No 
Yes 
 
 
196 (73.4) 
71 (26.6)
 
 
171 (63.1) 
100 (36.9)
 
 
77 (69.4) 
34 (30.6)
 
 
95 (55.3) 
77 (44.8)
1.48 (1.10, 1.99) 0.010 1.32 (0.97, 1.79) 0.074
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Table 8.  Adjusted Odds Ratios (Models 1-3) of Factors Associated with Current Adulthood Obesity, ESTHER Project, Pittsburgh, PA, 2003-2006 
 Model 1 
(AOR, 95% CI) 
P Model 2 
(AOR, 95% CI) 
P Model 4 
(AOR, 95% CI) 
P 
Age  * 0.99 (0.98, 1.02) 0.981 0.99  (0.98, 1.02)  0.941 0.99  (0.98, 1.02) 0.999 
Race   
African American 
Caucasian American 
 
Baseline 
2.87 (1.59, 5.17) 
<0.001  
Baseline 
3.02 (1.68, 5.43)  
<0.001  
Baseline 
3.02 (1.68, 5.43) 
<0.001 
Sexual Orientation   
Heterosexual 
Lesbian 
 
Baseline 
 1.44 (1.04, 1.98) 
0.027  
Baseline 
1.50 (1.09, 2.07)  
0.014  
Baseline 
1.51 (1.10, 2.08) 
0.012 
Education   
High School or Less 
Some college 
BA 
Graduate 
 
Baseline 
1.09 (0.62, 1.91) 
0.60 (0.33, 1.07) 
0.57 (0.32, 0.99) 
0.006  
Baseline 
1.10 (0.63, 1.93)  
0.58 (0.32, 1.03)  
0.55 (0.31, 0.97)  
0.003  
Baseline 
1.09 (0.62, 1.92) 
0.59 (0.33, 1.05) 
0.55 (0.31 0.96) 
0.003 
Household Income 
<$25 
$25K-$39K 
$40K-$59K 
$60K-$74K 
$75+ 
 
Baseline 
0.80 (0.47, 1.4) 
0.93 (0.55, 1.57) 
1.11 (0.61, 2.02) 
0.48 (0.27, 0.84) 
0.007  
Baseline 
0.79 (0.46, 1.37)  
0.91 (0.54, 1.54)  
1.08 (0.59, 1.96)  
0.49 (0.28, 0.85)  
0.012  
Baseline 
0.79 (0.46, 1.37) 
0.91 (0.54, 1.54) 
1.11 (0.61, 2.02) 
0.49 (0.28, 0.85) 
0.009 
Relationship       Yes 
No 
Baseline 
0.90 (0.62, 1.31) 
0.586 Baseline 
0.91 (0.63, 1.32)  
0.629 Baseline 
0.92 (0.64, 1.33) 
0.669 
History of Mental 
Health Diagnosis 
No 
Yes 
 
Baseline 
1.41 (1.02, 1.94) 
0.036  
Baseline  
1.46 (1.06, 2.01)  
0.021  
Baseline 
1.45 (1.05, 2.00) 
0.023 
CSA by a Family 
member                No 
Yes 
 
Baseline 
1.56 (1.09, 2.24) 
0.015      _________ _____      _________ _____
CSA Non-Family 
member                No 
Yes 
     _________ _____ Baseline 
1.10 (0.76, 1.59)  
0.612      _________ _____
ASA                      No 
Yes 
     _________ _____      _________ _____ Baseline 
1.11 (0.80, 1.55) 
0.517 
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Table 8.  Continued 
 
* Continuous variable 
Model 1: Adjusted for age, race, sexual orientation, education, household income, relationship status, history of previous mental health diagnosis, and 
CSA by a family member and interactions  
Model 2: Adjusted for age, race, sexual orientation, education, household income, relationship status, history of previous mental health diagnosis, and 
CSA by a non-family member  
Model 3: Adjusted for age, race, sexual orientation, education, household income, relationship status, history of previous mental health diagnosis, and 
ASA by a family member   
 
 
  
Table 9.  Adjusted Odds Ratios (Models 4) of Factors Associated with Current Adulthood Obesity, ESTHER 
Project, Pittsburgh, PA, 2003-2006 
 
 Model 4  (SA-Ever) 
(Adjusted OR, 95% 
Confidence Interval) 
p-value 
Age * 0.99  (.98, 1.02) 0.985 
Race   
African American 
Caucasian American 
 
Baseline 
3.01 (1.67, 5.40) 
<0.001 
Sexual Orientation   
Heterosexual 
Lesbian 
 
Baseline 
1.49  (1.08, 2.06) 
0.015 
Education   
High School or Less 
Some college 
BA 
Graduate 
 
Baseline 
1.09  (0.62, 1.92) 
0.59 (0.33, 1.05) 
0.55 (0.31, .96) 
0.003 
Household Income 
<$25 
$25K-$39K 
$40K-$59K 
$60K-$74K 
$75+ 
 
Baseline 
0.79  (0.46, 1.36) 
0.91  (0.54, 1.54) 
1.10   (0.60, 2.00) 
0.48  (0.28, 0.85) 
0.009 
Relationship 
Yes 
No 
 
Baseline 
0.92  (0.64, 1.33) 
0.660 
History of Mental 
Health Diagnosis 
No 
Yes 
 
 
Baseline 
1.44 (1.04, 1.98) 
0.027 
Lifetime History of 
Sexual Abuse (N=  ) 
No 
Yes 
 
 
Baseline 
1.15 (0.84, 1.59) 
0.380 
* Continuous variable 
Model 4: Adjusted for age, race, sexual orientation, education, household income, relationship status, history 
of previous mental health diagnosis, lifetime history of sexual abuse (ever)  
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5.1 ABSTRACT 
Objectives:  Polycystic ovary syndrome (PCOS), the most common endocrine disorder 
occurring in 4%  to  10% of reproductive-age women, is associated with adverse health 
outcomes such as infertility, cardiovascular disease, and Type II Diabetes.   Despite physician 
suspicions  that  lesbians  may  have  higher  rates  of  PCOS  than  heterosexual  women, only 
two published studies with conflicting results exist.  The aim of this study was to explore 
polycystic ovary syndrome (PCOS) among heterosexual and lesbian women in a general, healthy 
population of women.   
Methods:  Women who participated in the ESTHER Project (Epidemiologic STudy of HEalth 
Risk in Women, 2003-2006) were invited to participate in this study.  Analysis was based on 
self-reported information collected through the ESTHER Project, a mailed questionnaire, and 
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blood assays.   The total sample used for analysis included 117 lesbians and 100 heterosexuals 
who were between ages 35 and 45.  
Results:    Although not significant, lesbians had higher rates of having a research diagnosis of 
PCOS (9.6% and 4.0%, p=.110) and of being previously diagnosed with PCOS by a medical 
professional (7.8% and 2.0%; p=.053) compared to heterosexual women.   Lesbians had higher 
rates of hirsutism and reported history of polycystic ovaries (PCO), and slightly higher 
testosterone and androstenedione concentrations compared to heterosexuals; however, none were 
significant.  Compared to non-PCOS women, those with PCOS had significantly higher 
androstenedione (p<0.0001) and testosterone (p<0.001) concentrations and lower SHBG 
(p<0.0001) concentrations; and higher rates of oligomenorrhea (p=0.006), hirsutism (p<0.0001), 
and reported history of PCO (p<0.0001).  PCOS-related factors among women who had PCOS 
did not significantly differ by sexual orientation; however, lesbians had higher rates of self-
reported PCO history compared to heterosexuals.  
Conclusion: This study was the first to examine PCOS rates by sexual orientation in a general 
population of women.  Due to a small sample size definitive differences could not be confirmed 
for PCOS status by sexual orientation; however, if the trends observed are reflected in the larger 
population, then lesbian populations may: (1) have a higher prevalence of PCOS, (2) differ in the 
determinate factors of PCOS, and (3) be more likely to be diagnosed with PCOS by medical 
professionals than heterosexual women.   
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5.2 INTRODUCTION 
Polycystic ovary syndrome (PCOS) is a common endocrine disorder occurring in 4% to 10% of 
reproductively aged women in the general population.86-88  It is associated with an increased risk 
of infertility, cardiovascular disease (CVD), endometrial cancer (EC), and Type II diabetes. 89 
The theory that a lesbian sexual orientation is associated with specific biological determinants, 
such as elevated levels of androgen concentrations, has been used to support the hypothesis that 
higher rates of polycystic ovaries (PCO) and PCOS may occur in lesbian compared to 
heterosexual women. 86 87  It is currently unclear if the prevalence or symptoms of PCOS differ 
by sexual orientation.  The two published studies that examined this association have revealed 
conflicting results. 
Agrawal and colleagues’ reported that compared to heterosexual women, lesbian women 
had higher rates of PCO (80% and 32%) and PCOS (38% and 14%).   They found that among 
women with PCOS, lesbians had significantly higher rates of oligomenorrhea/amenorrhea; 
elevated concentrations of serum testosterone and androstenedione; and lower sex hormone-
binding globulin (SHBG) than their heterosexual counterparts.  Similar results were found 
among women with PCO; however androstenedione levels did not significantly differ by sexual 
orientation. 86   In contrast, De Sutter and colleagues revealed that rates of PCO, PCOS, and 
oligomenorrhea/amenorrhea did not significantly differ by sexual orientation.87  
Biochemical/clinical hyperandrogenism results were not reported due to missing data in patient 
files.  More research examining the association between PCOS and sexual orientation is greatly 
needed.  
If PCOS does occur more frequently among lesbians than among heterosexual women, 
lesbians may be at greater risk for PCOS-related health concerns.  Primary care physicians 
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should be aware of this potential health concern.  The purpose of this study was to further 
examine the relationship between sexual orientation and PCOS in a general population of 
women.  Our aim was to determine if the prevalence and features of PCOS differed by sexual 
orientation.      
5.3 METHODS 
5.3.1 Study Design and Data Collection  
All women aged 35 to 45 enrolled in the Epidemiologic STudy of HEalth Risk in Women 
(ESTHER) Project (2003-2006) were eligible to participate in our study.  The ESTHER Project 
was a large (N=1084) cross-sectional study that examined risk factors for heart disease among 
lesbian and heterosexual women in the Pittsburgh, Pennsylvania area.  Inclusion criteria for the 
ESTHER Project included:  self-identification as a heterosexual or lesbian woman, no previous 
history of heart disease (angina, heart attack, and stroke), and at least 35 years of age.   Study 
information used for our analysis was obtained from ESTHER Project recruitment call forms, 
self-administered questionnaires, clinical measurements, and blood assays.  In addition to 
ESTHER data, we collected detailed information on lifetime menstrual history, medical history, 
and hormone use, and ran hormone assays on stored blood samples. 
Mailing and telephone recruitment strategies were used to enroll women in this PCOS 
study.  A total of 401 women aged 35 to 45 were mailed study invitations and questionnaires in 
April and July of 2008.  After the second mailing, recruitment phone calls and interviews were 
made with women who did not respond.  After recruitment ended, hormone assays (total 
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testosterone, androstenedione, and SHBG were completed.   All study instruments and protocol 
were approved by the University of Pittsburgh’s Institutional Review Board (IRB).  Signed 
consent forms were obtained from each participant.     
5.3.2 Study Population 
Women met eligibility criteria for our study if they were between the ages of 35 and 45, had at 
least one ovary, and displayed no menopausal symptoms.  Women who had normal hormone 
(testosterone and androstenedione) levels and were currently taking oral contraceptives (OCs) at 
the time of the blood draw were ineligible.  OCs are used to regulate hormone levels and 
menstrual cycles and would have interfered with making a PCOS diagnosis.  Of the 401 women 
eligible for our study, 251 (63% response rate) agreed to participate.  A total of 31 women were 
disqualified because they did not meet study criteria, therefore our analysis was based on a total 
of 217 women (lesbian, N=117; heterosexual N=100).  Although this sample size did not provide 
sufficient power to detect statistically significant differences between lesbian and heterosexual 
women, meaningful trends were observed.   
5.3.3 Measures 
Polycystic Ovarian Syndrome (PCOS) 
The Rotterdam 2003 criteria for PCOS is widely used by medical professionals and researchers 
to identify PCOS.  Using this criteria, PCOS is diagnosed when at least two of the following 
three criteria are met:  (1) biochemical and/or clinical hyperandrogenism, (2) oligo- or 
anovulation and (3) polycystic ovaries after exclusion of known disorders (Cushing’s syndrome, 
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androgen-secreting tumors, and congenital adrenal hyperplasias).90  For the purposes of our study 
PCOS cases were identified by a reproductive endocrinologist using a modified version of the 
2003 Rotterdam Criteria.  Our modified version was based primarily on self-reported 
information:   presence of adult acne; excessive hair growth; menstrual history; and history of 
being diagnosed with PCO, Cushing’s syndrome, androgen-secreting tumors, and/or congenital 
adrenal hyperplasias.  Hormonal assays were completed to determine biochemical 
hyperandrogenism. 
Biochemical hyperandrogenism was identified by elevated testosterone and 
androstenedione concentrations.    All blood assays were conducted by the Nutrition Laboratory 
in Graduate School of Public Health at the University of Pittsburgh. Total testosterone was 
measured using the commercial enzyme immunoassay (EIA) kit (DSL-10-4000) bought from 
Diagnostic Systems Laboratories (Webster, Texas).  The expected testosterone values, using this 
protocol, for women 30 to 40 years old range from <0.1 to 2.2 ng/ml and in women 40 to 50 
years old from <0.1 to 0.90 ng/ml.  Lab results indicated consistently high testosterone levels 
throughout the study population.  The reason for these high values was unclear. The low (0.5 
ng/ml) and high (5.0 ng/ml) control samples provided with the kit were validated and within the 
anticipated physiological range.  The duplicate values were in good agreement and all high study 
values were repeated and confirmed.  Information provided with the protocols indicated that 
cross-reactivity of the antibody with other analyses was low; however, it cannot be ruled out that 
a component in the matrix was interfering with the antibody employed. A legitimate procedure 
administered in situations like this, and with our sample size, is to use one standard deviation 
away from the sample mean as the new cutoff point.91  In our case the cutoff value indicating a 
high testosterone value was > 3.4 ng/ml, which was given to us by the University of Pittsburgh’s 
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Nutrition Laboratory.  Androstenedione was measured using an enzyme-link immunosorbent 
assay (ELISA) developed by the American Laboratory Products Company (ALPCO, #11-
ANRHU-EO1; Salem, NH).  The expected value for androstenedione in women is 1.4 ng/ml 
(range: 0.3 to 2.4 ng/ml).  Women with androstenedione levels >2.4 were considered to have 
elevated androstenedione concentrations, and considered for PCOS diagnosis.     
Clinical hyperandrogenism was based on self-reported current adult acne and hirsutism 
(excessive hair growth) collected by the ESTHER Project.  Hirsutism was determined using the 
modified Feriman-Gallway scale in which women marked seven body areas (0 to 4) according to 
their hair density.92  Having a score of 8 or higher indicated excessive hair growth (hirsutism).  
The standard definition of oligomenorrhea, menstrual periods more than 40 days apart and/or 
menstruating less than 9 times per year, was used for study purposes.  Menstrual history 
information was collected through ESTHER questionnaires and our mailed questionnaire.  
Medical professionals use ultrasound technology and strict diagnostic guidelines to screen for 
PCO among patients.  Because diagnostic ultrasounds were beyond the scope of this study, self 
reported PCO history was used to help determine PCOS cases.  PCO history was obtained using 
ESTHER data and PCOS exclusion etiologies were obtained through the mailed questionnaire.     
Demographic and PCOS-Related Factors 
Demographic information (race, age, sexual orientation, ever given birth to a child, 
education, and household income) was obtained from baseline screening/recruitment forms and 
ESTHER Project questionnaires.  Heterosexuals were defined as those who self-identified as 
heterosexual or straight and only had male sexual partners since the age of 18.  Lesbians were 
defined as those:  who did not identify as heterosexual or straight and whose emotional, physical, 
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and romantic attractions within the past 5 years had been towards only or primarily women or 
whose relationships within the past 5 years had been with only or primarily women.  
Aside from demographics, PCOS-related factors were analyzed to help better understand 
potential differences between lesbian and heterosexual women:  reported family history of 
PCOS, reported infertility diagnosis, sex hormone-binding globulin (SHBG) concentrations, and 
body max index (BMI).  The mailed questionnaire also asked women if they ever had been 
diagnosed with PCOS by a medical professional.  Reported family history of PCOS and 
infertility diagnoses were obtained through self-administered questionnaires collected by the 
ESTHER Project.  
SHBG concentrations were analyzed at the same time the androstenedione and 
testosterone assays were prepared, and were measured using an ELIZA procedure developed by 
ALPCO (#11-SHB HU-E01; Salem, NH). The expected value for SHBG in women is 50 nmol/L 
(range: 15 to 120 nmol/L).   Reported family history of PCOS and previous infertility diagnosis 
were obtained through ESTHER questionnaires.  The height and weight measurements used to 
calculate  BMI  were  taken  by the ESTHER Project during the first clinic visit.  BMI was 
calculated as weight in kilograms divided by the square of height in meters [weight (kg)/height 
(m)2].  The National, Heart Lung and Blood Institute (NHLBI)-defined cutoff categories were 
used to measure body mass index (BMI): <18.5 (underweight), 18.5 to 24.9 (normal), 25.0 to 
29.9 (overweight), 30.0 to 34.9 (mildly obese); 35.0 to 39.9 (severely obese) and > 40 (morbidly 
obese).67   For the purposes of this analysis, the following BMI categories were created: <25 
(underweight/normal); 25.0 to 29.9 (overweight) and >30.0 (obese).     
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5.3.4 Statistical Analysis 
Fisher’s exact tests and Chi squared tests were performed to determine differences between 
categorical variables.  For comparison of continuous variables, the Exact Wilcoxon and 
Wilcoxon rank sum tests were used.  A p-value <0.05 was used to determine statistical 
significance.  All statistical analyses were performed using the SAS system for Windows, 
version 9.2 (SAS Institute, Cary, North Carolina).  
5.4 RESULTS 
Overall the median age of women in the study was 41.0 years (Table 10).  Most women had a 
bachelors degree or higher (N=133, 61.9%), a household income greater than $40K (N=139, 
64.7%), and reported currently being in a committed relationship (N=164, 76.6%).  The 
racial/ethnic composition of the study was 85.1% (N=183) Caucasian, 12.6% (N=27) African 
American, 0.93% (N=2) Asian, 0.93% (N=2) Native American, and 0.47% (N=1) who identified 
as “other’.  Racial/Ethnic background (p<0.0001) and having given birth to a child (p<0.0001) 
were the only two demographic factors that significantly varied between heterosexual and 
lesbian women.   Significantly more African American heterosexuals participated in the study 
than African American lesbians (N=22, 22.0% and N=5, 4.4%).   
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5.4.1 Diagnosis of PCOS 
Approximately 7.0% (N=15) of the sample was given a research diagnosis of PCOS.  The 
majority 40.0% (N=6) of PCOS cases were identified by means of reported PCO history and 
clinical hyperandrogenism.  The remaining cases were acknowledged as follows: 20.0% (N=3) 
PCO history and biochemical hyperandrogenism; 20.0% (N=3) PCO history and both clinical 
and biochemical hyperandrogenism; 13.3% (N=2) oligomenorrhea and biochemical 
hyperandrogenism; and 6.7% (N=1) PCO history, oligomenorrhea and clinical 
hyperandrogenism.  Using our PCOS diagnostic criteria, lesbians were found to have higher rates 
of PCOS than heterosexuals (N=11, 9.6% and N=4, 4.0%); however, this difference was not 
statistically significant (P=0.110).  Of the 15 women who were given a research diagnosis of 
PCOS, 93.3% (N=14) were Caucasian and slightly more than half reported being given a PCOS 
diagnosis by a medical professional (53.3%, N=8).   
5.4.2 Comparison of PCOS-Related Factors between Heterosexual and Lesbian Women 
Heterosexual women were found to have higher rates of oligomenorrhea (N=19, 19.0% and N=9, 
7.8%; p=0.015); however, after accounting for age no significant difference was found.  Having 
a history of PCO (N=13, 11.3% and N=6, 6.0%) and hirsutism (N=29, 25.2% and N=15, 15.0%) 
did not differ significantly by sexual orientation, however, lesbians had higher reported rates 
than heterosexuals.  Similarly, although not significant, lesbians had higher rates of elevated 
testosterone (N=10, 8.7% and N=6, 6.0%) and androstenedione (N=11, 9.6% and N=6, 6.0%) 
concentrations, and higher rates of being obese (N= 43, 37.4% and N=33, 33.0%) than 
heterosexuals.  Heterosexual women had a higher rate of being diagnosed with infertility 
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compared to lesbians (N=6, 6.0% and N=2, 1.74%), but this was not significant. Regardless of 
PCOS diagnosis, lesbians had higher reported rates of being given a previous PCOS diagnosis by 
a medical professional compared to heterosexuals (N=9, 7.8% and N=2, 2.0%, p = .053), which 
approached significance.  Rates of adult acne and family history of PCOS were similar between 
heterosexual and lesbian women. 
5.4.3 Comparison of Non-PCOS and PCOS Women 
As expected when compared to non-PCOS women those with PCOS had significantly higher 
median androstenedione (p<0.0001) and testosterone concentrations (p<0.0001), and lower 
SHBG concentrations (p<0.0001) (Table 11).   Women with PCOS had significantly higher rates 
of oligomenorrhea (p=0.006), hirsutism (p<0.0001), PCO history (p<0.0001), and family history 
of PCOS (p=.013) compared to non-PCOS women.  Women without PCOS had higher rates of 
reported childbirth than women with PCOS (P=.015).   Although not significant, there was a 
trend for women with PCOS to be more overweight and obese compared to non-PCOS women.   
The results found no significant association between adult acne by research PCOS diagnosis.   
5.4.4 Comparison of PCOS Status by Sexual Orientation  
Of the women who did not have PCOS, lesbians had significantly lower rates of oligomenorrhea 
(N=6, 5.8 % and N=16, 16.7%; p=.014) (Table 12); however, this was not significant after 
accounting for age.  Lesbians were less likely to have given birth (N=18, 16.4% and N=74, 
77.1%; <0.0001) than heterosexual women.   There were no other significant differences found 
among non-PCOS women by sexual orientation group; however, potential trends were noted.  
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Although not significant, non-PCOS lesbians had higher rates of having a BMI>30 (N=39, 
37.5% and N=30, 31.3%), hirsutism (N=19, 18.3% and N=11, 11.5%), and slightly higher 
median concentrations of testosterone (1.53 and 1.63) and androstenedione (1.52 and 1.62) than 
non-PCOS heterosexuals.  Lesbians had a lower rate of a reported infertility diagnosis (N=2, 
1.9% and N=5, 5.2%), however this was not significant.   Rates of PCO diagnosis, current adult 
acne, and a family history of PCOS did not vary by sexual orientation among non-PCOS women.   
 No significant differences were found between lesbian and heterosexual women who had 
a research PCOS diagnosis.  Non-significant trends for factors related to PCOS were noted.  
Lesbians with PCOS had higher reported rates of PCO diagnoses (N=8, 72.7% and N=2, 50.0%) 
and being overweight (N=5, 45.5% and N=1, 25.0%) than heterosexual women; but 
heterosexuals with PCOS had higher rates of being obese (N=3, 75.0% and N=4, 36.4%) and 
having given birth (N=2, 50.0% and N=0, 0%).   Rates of oligomenorrhea, current adult acne, 
family history of PCOS, and infertility; and median concentrations of androstenedione, 
testosterone, and SHBG did not significantly differ between lesbian and heterosexual women 
with PCOS.   
5.5 DISCUSSION 
The purpose of this study was to explore prevalence rates of PCOS and associated factors in a 
sample of heterosexual and lesbian women.  The two published studies exploring this potential 
relationship were conducted among patients in fertility clinics.  Fertility clinics are a logical 
setting to explore this research question because: (1) physicians are exposed to a higher 
percentage of women with PCOS than found in the general population and (2) many lesbians 
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trying to conceive use fertility services.  Although logical, this setting could introduce a research 
bias because lesbians and heterosexual women may use fertility clinics for different reasons.  
Often lesbians who use fertility clinic services do not have infertility concerns; they seek fertility 
clinics to obtain sperm and/or for physician advice and services to become pregnant.  Many 
heterosexual women attend fertility clinics because either they and/or their male partners have 
fertility problems.  Therefore, we should expect to see a lower prevalence of PCOS among 
lesbians compared to heterosexual women who attend fertility clinics.  Surprisingly, neither 
study came to this conclusion.   
Agrawal and colleagues reported that lesbians were significantly more likely to have 
PCOS (38% and 14%; p<.0001) while De Sutter and colleagues reported no significant 
difference in PCOS status by sexual orientation group (8.0% lesbian and 8.7% heterosexual).  
Regarding determinants of PCOS, Agrawal et al. revealed that lesbians with PCOS had 
significantly higher rates of oligomenorrhea/amenorrhea (P<.0001), acne (P<.0001), and 
hirsutism (P<.0001); and higher mean androstenedione (P<.001) and testosterone (P<.01) and 
lower SHBG (P<.001) concentrations than heterosexuals with PCOS.  They did not share how 
PCO varied by PCOS status.  De Sutter et al. found no significant differences in rates of PCO 
and olig-amenorrhoea between lesbian and heterosexual women with PCOS; they did not discuss 
biochemical and clinical hyperandrogenism because of missing data from patient files.   
Although our study is based on a small sample of women with only fifteen women 
identified as having PCOS, and lacked the power to detect statistically significant differences in 
PCOS prevalence between lesbian and heterosexual women, meaningful trends were observed.  
Results should be interpreted with caution.  The prevalence of PCOS found among this sample 
(7.0%) falls within the expected range reported by most studies (4.0% to 10.0%, respectively).86-
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88  Overall, results showed that lesbians had higher rates of having a research PCOS diagnosis 
compared to their heterosexual counterparts (9.6% and 4.0%, respectively).   Lesbians also had 
higher rates than heterosexuals of having been previously diagnosed with PCOS by a medical 
professional (7.8% and 2.0%).   Interestingly, among women who had been diagnosed with 
PCOS by a medical professional (N=11), about 82% (N=8) were lesbian; this difference 
approached significance (p = 0.053).   When examined even closer, among women who reported 
being previously diagnosed with PCOS and were given a research PCOS diagnosis, 75% (N=6) 
were lesbian.  Among women who had reported a history of PCOS but did not meet our study 
criteria of PCOS, 100% (N=3) were lesbian.  This leads us to the question, are lesbians possibly 
being diagnosed more frequently because they have PCOS and/or because they have particular 
characteristics that would make medical professionals more likely to diagnose them with PCOS?  
Perhaps lesbians have certain characteristics or features that may make physicians more likely to 
diagnose them with PCOS.  Conclusions to these questions cannot be made based on our data; 
however, future research studies could examine these hypotheses.  
Potential differences in PCOS-related factors may exist with regard to sexual orientation 
and PCOS status.  Although not significant, lesbians had higher rates of reported PCO, hirsutism, 
and obesity than heterosexuals in our sample.   In addition, higher (non-significant) median 
androstenedione and testosterone concentrations were found in lesbians compared to 
heterosexuals.  Rates of reported infertility were higher among heterosexuals compared to 
lesbians, which was also true among women with PCOS; however in both cases no significant 
differences were found.  This result was expected because heterosexuals generally attempt and/or 
have children more frequently than lesbians. Compared to non-PCOS women, those with PCOS 
had higher androstenedione and testosterone and lower SHBG concentrations, which concur with 
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results reported from prior research studies.  As expected, women with PCOS had significantly 
higher rates of oligomenorrhea, hirsutism, PCO history, and family history of PCOS than non-
PCOS women. Although not significant, women with PCOS were heavier than non-PCOS 
women.  Women who did not have PCOS were significantly more likely to have given birth to 
children.  No significant differences were found between heterosexual and lesbian women who 
had PCOS; however, lesbians reported higher rates of being previously diagnosed with PCO and 
being overweight while heterosexuals had higher rates of having given birth and being obese.    
Although this study did not have the statistical power to detect a significant difference in 
PCOS prevalence among lesbian and heterosexual women, meaningful trends were observed.  If 
the trends observed are reflective of the larger population, lesbians may (1) may exhibit 
differences in PCOS features, (2) have higher rates of PCOS, and (3) perhaps even be more 
likely to be diagnosed with PCOS compared to heterosexuals.  Future research should aim to 
investigate this potential difference in a larger sample of women, and explore the potential of 
diagnostic bias for PCOS among lesbian women.  
5.6 LIMITATIONS 
To date the two research papers examining the prevalence of PCOS among lesbian and 
heterosexual women, as well as our study, have different research definitions of lesbian sexual 
orientation.   This makes it difficult to compare results across studies.  Agrawal and colleagues’ 
definition of lesbian was based on “historical and current information obtained during the 
assent”.86  This definition does not inform readers if a lesbian sexual orientation was determined 
by same-sex attraction, previous sexual history, and/or self-identification as a lesbian.  De Sutter 
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and colleagues defined a lesbian sexual orientation according to the gender of each participant’s 
current partner, and therefore all single women were excluded from their study.   This limits their 
study because single heterosexual women and lesbians may attend fertility clinics more for the 
same reasons (lack of a male partner) compared to heterosexual women in relationships.  It could 
be hypothesized that single women and lesbians who attend fertility clinics may have lower rates 
of fertility problems, like PCO and PCOS, than women in heterosexual relationships.  Also, both 
studies did not clarify if bisexual women were grouped with the lesbians, or if they were 
disqualified from their study.  Bisexual women could possibly skew results, making lesbian 
women appear to have similar characteristics and risk factors as heterosexual women.  Our 
analysis was based on the ESTHER research definition of lesbian sexual orientation which 
included sexual attraction, previous sexual history, and self-identification as a lesbian.  Women 
who were identified as having a bisexual sexual orientation did not qualify.   It would be 
beneficial if future studies would explore if PCOS prevalence rates are consistent across different 
definitions of lesbian sexual orientation.  A limitation to our definition is that we only were able 
to report on women who were “out” as being a lesbian to a certain degree.  Results do not 
represent lesbian women who have a “closeted” sexual orientation.  It is possible that some 
women did not feel comfortable reporting same sex attraction, behavior, or identity and therefore 
would have been mistakenly placed in the heterosexual group.  
This study has several limitations.  First, our PCOS definition was based primarily on 
self-reported data.  Unfortunately funding was not available to perform ultrasounds; to conduct 
blood assays of all biochemical measures associated with PCOS; and to have a physician 
physically diagnose PCOS, clinical hyperandrogenism, and oligomenorrhea.  We did however 
have a reproductive endocrinologist on our team to review menstrual history, biochemical 
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measures of hyperandrogenism (testosterone and androstenedione), and make probable PCOS 
diagnoses.     
As mentioned, we were unable to confirm whether participants in our study had PCO 
through ultrasound technology, which is the gold standard of diagnosing PCO.   PCO is defined 
as having at least 8-10 follicles measuring 2-9 mm in diameter on one or both ovaries, increased 
stroma, and an ovarian volume > 6 ml in nulliparous and 8 ml in parous women. 93   It is possible 
that some participants who reported having a history of PCO did not have PCO.  They may have 
confused PCO with having a cyst(s) on their ovary; having a cyst(s) on one’s ovary is not the 
same diagnosis as PCO.89  Conversely, some women may have been unaware that they had PCO 
which could have underestimated the prevalence of PCO, and PCOS, in our sample.   
Another  limitation  is  that results represent primarily white women of a stringent age 
range.  This occurred for two reasons (1) the ESTHER Project only included women who were 
age 35 or older, and (2) the age limit for our study was 45 to eliminate menopausal women from 
underestimating our PCOS rate.  Research has suggested that hyperandrogenism may decrease 
around the age of menopause in women with PCOS, which may explain why some women with 
PCOS begin to menstruate more regularly as they age.94   If women over 45 were included, it 
would have been difficult to identify women with PCOS because (1) decreased menstrual 
periods per year could be the result of menopause, (2) more women would have been 
disqualified for exhibiting menopausal symptoms, and (3) hormonal assays of androstenedione 
and testosterone may have been unable to detect potential PCOS cases.  Lastly, findings reported 
in this paper represent women with PCOS who did not have a previous history of coronary heart 
disease.  Prior studies have shown that PCOS is associated with an increased risk for heart 
   71
disease95; therefore, our PCOS prevalence rate may underestimate the true PCOS prevalence rate 
found in general populations of women. 
5.7 CONCLUSION 
Despite these limitations our findings make a valuable contribution to the literature examining 
the relationship between PCOS and sexual orientation.  As mentioned previously, only two 
published studies investigating this relationship exist; both conducted in fertility clinics.  Ours 
was the first to examine PCOS and PCOS-related factors among a general population of 
heterosexual and lesbian women.   Although we did not have adequate power to detect 
significant differences, we did find that rates of having a research PCOS diagnosis and of being 
previously diagnosed with PCOS by a medical professional were higher among lesbians 
compared to heterosexual women.  Results indicate that PCOS-related factors may also vary by 
sexual orientation.  Although not significant, lesbians had higher rates of being previously 
diagnosed with PCO and hirsutism compared to heterosexuals.  Among women who had PCOS, 
lesbians had non-significantly higher rates of reported PCO and being obese compared to 
heterosexual.  
Our pilot data leads us to three questions for future research:  (1) Do lesbians truly have 
higher rates of PCOS in both general and clinic populations?; (2) Do PCOS-related factors vary 
by sexual orientation?; and  (3) Regardless of true PCOS status, are medical professionals more 
likely to diagnosis lesbians than heterosexuals with PCOS?  If medical professionals are more 
likely to diagnose lesbians with PCOS, this could explain higher PCOS rates found among 
lesbians compared to heterosexuals.  Future research could explore whether lesbians who have 
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androgynous/butch gender identities are more likely to be diagnosed with PCOS than lesbians 
with feminine appearances or heterosexual women.   Future studies could also investigate if 
disclosure of a lesbian sexual identity to a primary care physician increases the likelihood of 
being diagnosed with PCOS. 
 
5.8 PAPER 3 TABLES 
Table 10.  Comparison of Demographic and PCOS-Related Factors Between Lesbian and Heterosexual 
Women, Polycystic Ovary Syndrome Study, Pittsburgh, PA, 2008 
 
Variable Total 
(N=215) 
Heterosexual 
(N=100) 
Lesbian 
(N=117) 
P 
Age*  41.0 41.0 41.0 0.663
Race (%)  
African American 
Caucasian 
Other 
 
 27 (12.6)
183 (85.1) 
    5 (2.3) 
 
 22 (22.0) 
 75 (75.0) 
   3 (3.0) 
  
 5 (4.4)  
108 (93.9)  
    2 (1.7)  
<0.0001 
Sexual Orientation (%)  
Heterosexual 
Lesbian 
100 (46.5)
117 (53.5)
 
---------  
 
---------  
 
---------  
Education (%)  
HS or Less 
Some College 
Bachelors 
Graduate 
 16 (7.4)
 66 (30.7)
 57 (26.5)
 76 (35.4)
 
10 (10.0) 
 34 (34.0) 
 23 (23.0) 
 33 (33.0)
  
   6 (5.2) 
 32 (27.8) 
 34 (29.6) 
 43 (37.4) 
0.325
Income (%)  
<$25K 
$25K-$39K 
$40K-$59K 
$60K-$74K 
$75K 
 
29 (13.6)
  45 (21.1)
  47 (22.1)
  28 (13.2)
  64 (30.1)
 
16 (16.3) 
 19 (19.4) 
 17 (17.4) 
   9 (9.2) 
 37 (37.8)
  
13 (11.3) 
 26 (22.6) 
 30 (26.1) 
 19 (16.5) 
 27 (23.5) 
0.067
In a Committed Relationship 
(%)  
164 (76.6)  75 (75.8)  89 (77.4) 0.778
Given Birth (%)    93 (43.3)  76 (76.0)   17 (14.8)  <0.0001 
Research PCOS Diagnosis (%)    15 (7.0)    4 (4.0)  11 (9.6)  0.110 
History of PCOS Diagnosis 
(%)  
  11 (5.1)    2 (2.0)    9 (7.8)  0.053 
   73
Table 10.  Continued 
 
Variable Total 
(N=215) 
Heterosexual 
(N=100) 
Lesbian 
(N=117) 
P 
PCO History (%)    19 (8.8)    6 (6.0)   13 (11.3)  0.172 
Oligomenorrhea (%)    28 (13.02)  19 (19.0)     9 (7.8)  0.015 
Hirsutism (%)    44 (20.5)  15 (15.0)   29 (25.2)  0.064 
Adult Acne (%)    49 (22.8)  25 (25.0)   24 (20.9)  0.471 
Family History of PCOS (%)     3 (1.4)    2 (2.0)    1 (0.87)  0.599 
Previous Infertility Diagnosis 
(%)  
   8 (3.7)    6 (6.0)    2 (1.74)  0.149 
BMI 
<25 
25-29.9 
>30.0 
  
 83 (38.6)
56 (26.1)
76 (35.4)
 
42 (42.0) 
25 (25.0) 
33 (33.0)
 
41 (35.7) 
31 (27.0) 
43 (37.4) 
0.629
Testosterone Concentration  
> 3.4 l (%) (ng/ml) 
  16 (7.4)    6 (6.0)   10 (8.7)  0.453 
Androstenedione 
Concentration 
 > 2.4 (%) (ng/ml) 
  17 (7.9)    6 (6.0)   11 (9.6)  0.334 
BMI * 27.0 26.0 27.2  0.245 
Testosterone* 1.56 1.54 1.70  0.112 
Androstenedione* 1.57 1.52 1.63  0.126 
SHBG* 43.7 44.3 43.0  0.816 
* Mean (SD) 
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Table 11.  Comparison of Demographic and PCOS-Related Factors by Research PCOS Diagnosis, Polycystic 
Ovary Syndrome Study, Pittsburgh, PA, 2008 
 
Variable No PCOS 
(N=200) 
PCOS 
(N=15) 
P 
Age*  41.0 41.0 0.798
Race (%)  
African American 
Caucasian 
Other
 
  27 (13.5) 
169 (84.5) 
  4 (2.0)
 
   0 (0.0) 
 14 (93.3) 
   1 (6.67) 
0.120
Sexual Orientation (%)  
Heterosexual 
Lesbian
 
  96 (48.0) 
104 (52.0)
  
 4 (26.7) 
  11 (73.3) 
0.110
Education (%)  
HS or Less 
Some College 
Bachelors 
Graduate
 
  16 (8.0) 
  60 (30.0) 
  54 (27.0) 
  70 (35.0)
 
   0 (0.0) 
   6 (40.0) 
   3 (20.0) 
   6 (40.0) 
0.728
Income (%)  
<$25K 
$25K-$39K 
$40K-$59K 
$60K-$74K 
$75K
 
  26 (13.1) 
  40 (20.2) 
  45 (22.7) 
  26 (13.1) 
  61 (30.8)
 
  3 (20.0) 
  5 (33.3) 
  2 (13.3) 
   2 (13.3) 
   3 (20.0) 
0.601
In a Committed Relationship (%)  154 (77.4)  10 (66.7) 0.350
Given Birth (%)  91 (45.5) 2 (13.3)  0.015 
History of PCOS Diagnosis (%)     3 (1.5)    8 (53.3)  <0.0001 
PCO History (%)     9 (4.5)  10 (66.7)  <0.0001 
Oligomenorrhea (%)    22 (11.0)    6 (40.0)  0.006 
Hirsutism (%)    30 (15.0)  14 (93.3)  <0.0001 
Adult Acne (%)    45 (22.5)    4 (26.7)  0.751 
Family History of PCOS (%)  1 (0.50) 2 (13.3)  0.013 
Previous Infertility Diagnosis (%)  7 (3.5) 1 (6.7)  0.445 
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Table 11.  Continued   
Variable No PCOS 
(N=200) 
PCOS 
(N=15) 
P 
BMI 
<25 
25-29.9 
>30.0
 
81 (40.5) 
50 (25.0) 
69 (34.5)
 
1 (13.3) 
6 (40.0) 
7 (46.7) 
0.080
Testosterone Concentration  
> 3.4 l (%) (ng/m) 
  14 (7.0)    2 (13.3)  0.309 
Androstenedione Concentration 
 > 2.4 (%) (ng/ml) 
  13 (6.5)    4 (26.7)  0.021 
BMI* 26.5 29.0  <0.0001 
Testosterone* 1.54 2.37  <0.0001
Androstenedione* 1.54 1.79  <0.0001
SHBG* 44.3 26.4  <0.0001
 
Table 12.  Comparison of Demographic and PCOS-Related Factors by Research PCOS Status and Sexual 
Orientation, Polycystic Ovary Syndrome Study, Pittsburgh, PA, 2008 
 
Variable No PCOS (N=202) PCOS (N=15) 
 Hetero. 
(N=96) 
Lesbian 
(N=104) 
P 
 
Hetero. 
(N=4) 
Lesbian  
(N=11) 
P 
 
Age* 41.0 41.0 0.787 39.0 41.0 0.419
Previous PCOS 
Diagnosis 
  0 (0.0)   3 (2.9) 0.247 2 (50.0)   6 (54.6) 0.99
Previous PCO 
Diagnosis 
  4 (4.2)   5 (4.8) 0.99 2 (50.0)   8 (72.7) 0.560
Oligomenorrhea 16 (16.7) 6 (5.8) 0.014 3 (75.0) 3 (27.3) 0.235
Hirsutism 11 (11.5) 19 (18.3) 0.178 4 (100.0) 10 (90.9) 0.99
Adult Acne 23 (24.0) 22 (21.2) 0.635 2 (50.0) 2 (18.2) 0.517
Testosterone 
Concentration  
> 3.3 (%) 
6 (6.3) 8 (7.7) 0.690 0 (0.0) 2 (18.2) 0.99
Androstenedione 
Concentration 
 > 2.4 (%) 
5 (5.2) 8 (7.7) 0.477 1 (25.0) 3 (27.3) 0.99
BMI 
<25 
25-29.9 
>30.0 
 
42 (43.8) 
24 (25.0) 
30 (31.3) 
 
39 (37.5) 
26 (25.0) 
39 (37.5)
0.593  
0 (0.0) 
1 (25.0) 
3 (75.0) 
 
2 (18.2) 
5 (45.5) 
4 (36.4)
0.585
Family History of 
PCOS 
1 (1.0) 0 (0.0) 0.480 1 (25.0) 1 (9.1) 0.476
Previous 
Infertility 
Diagnosis 
5 (5.2) 2 (1.9) 0.264 1 (25.0) 0 (0.0) 0.267
Given Birth 74 (77.1) 18 (16.4) <0.0001 2 (50.0) 0 (0.0) 0.057 
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Table 12.  Continued 
BMI* 26.0 27.1 0.210 38.8 28.5 0.131
Testosterone* 1.53 1.63 0.190 2.16 2.45 0.489
Androstenedione* 1.52 1.62 0.127 2.10 1.66 0.507
SHBG* 44.6 43.5 0.810 24.5 30.2 0.753
* Mean (SD) 
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6.0  OVERALL DISCUSSION 
6.1 SUMMARY OF FINDINGS 
This dissertation covered three separate research questions; each investigated a different aspect 
of lesbian health.   The first manuscript explored the prevalence and potential differences of 
CAM use among lesbian and heterosexual women.  Analyses revealed a high prevalence rate of 
CAM use ever and within the past 12 months among women who participated in the ESTHER 
Project, with lesbians reporting higher rates of CAM use than heterosexuals.  These findings, 
representing the second known manuscript discussing CAM use among a general population of 
healthy lesbian and heterosexual women, indicate that sexual orientation should be viewed as a 
demographic factor associated with CAM use.  Other significant factors associated with ever 
CAM use and CAM use within the past 12 months were comparable to other published studies:  
being Caucasian, having a higher education level, reporting perceived discrimination in a 
medical establishment, living in a large city, reporting being very spiritual, and having a history 
of a diagnosed mental health disorder.  Among the women who had used CAM in the previous 
12 months, types of CAM used did not significantly vary based on sexual orientation, except that 
heterosexual women were significantly more likely to have participated in yoga compared to 
lesbian women.  The second manuscript investigated the relationship of sexual orientation, 
sexual abuse history, and current adulthood obesity, and found that lesbians and women who 
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reported CSA by a family member were significantly more likely to be obese than heterosexuals 
and women who reported no CSA by a family member.  Other independent predictors of current 
adulthood obesity were:   having less education than a bachelors’ degree, a lower household 
income (<$75K), African American race, and history of a mental health disorder.  The third 
manuscript examined the prevalence of PCOS and related factors among heterosexual and 
lesbian women.  To investigate this research topic, qualified participants of the ESTHER Project 
were invited to take part in our PCOS study.  Information collected by the ESTHER Project, a 
mailed questionnaire, and additional blood assays were used for the analysis.  Although this 
study lacked the power to detect statistically significant differences, meaningful trends were 
observed.  Lesbians had a higher rate of having a research diagnosis of PCOS compared to 
heterosexual women (9.6% and 4.0%, respectively); and also had a higher rate of being 
previously diagnosed with PCOS by a medical professional compared to heterosexuals (7.8% 
and 2.0%, respectively).  Among PCOS cases, PCOS-related factors did not statistically differ by 
sexual orientation; however, this may be due to our small number of research PCOS cases 
(N=15).      
6.2 PUBLIC HEALTH SIGNIFICANCE 
Analyses in the first manuscript revealed that that sexual orientation was an important factor in 
understanding CAM use.  Additionally, we discussed that due to the high prevalence of CAM 
use found in our population, medical professionals should be encouraged to ask about the CAM 
practices of their female patients, particularly lesbians. The second manuscript explored the 
association of sexual orientation, sexual abuse history, and obesity.  Results suggested that a 
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lesbian sexual orientation and CSA by a family member were both significant predictors of 
adulthood obesity.   This indicates that there is a need for future studies and weight programs to 
consider how lesbian sexual orientation and CSA may influence weight gain, motivation to 
lose/maintain weight, and weight loss.  The third paper examined PCOS prevalence and PCOS-
related factors among heterosexual and lesbian women.   Findings indicate that if trends found in 
rates are true, lesbian populations may: (1) have a higher prevalence of PCOS, (2) differ with 
regard to PCOS-related factors, and (3) be more likely to be diagnosed with PCOS by medical 
professionals, than heterosexual women. These findings demonstrate the need for future PCOS 
studies to consider sexual orientation as a potential demographic factor when describing health 
outcomes related to PCOS and designing PCOS interventions or maintenance programs.   
6.3 STRENGTHS AND WEAKNESSES 
The three manuscripts presented have a number of notable strengths in common.  First, all 
statistical analyses were based on data collected by the ESTHER Project.  Unlike many lesbian 
studies, the ESTHER Project represents a large sample of both lesbian and heterosexual women.  
Although non-probability recruitment methods were used, multiple strategies were administered 
to maximize participation and all data were collected by trained research staff.  Another overall 
strength was that each manuscript filled a needed research gap in lesbian health research.   
Despite these strengths, the manuscripts have common limitations that must be 
considered when interpreting results.  First, conclusions were limited to the inclusion criteria and 
study protocol of the ESTHER Project.   Only women who were identified as lesbian or 
heterosexual, age 35 or older, had no previous history of heart disease, and lived in the 
   80
Pittsburgh, PA area were represented.  Sexual orientation was based on same-sex attraction, 
behavior, and self-identification; this specific definition has not been used consistently across 
lesbian health studies.  When comparing results it will be important to acknowledge not only 
how sexual orientation is defined,   but also other variables such as CAM and sexual abuse.   In 
addition, the ESTHER Project mainly represented Caucasian, highly educated, women who had 
household incomes above the national poverty index.  Many of the factors used for analyses were 
based on self-report; therefore, reporting bias may have influenced results in all three 
manuscripts.  Lastly, the ESTHER Project was a cross-sectional study, so results represent 
information collected at one point in time.  To help build a case for potential causality, 
longitudinal studies need to be conducted.  
6.4 FUTURE RESEARCH 
As previously mentioned, large-scale longitudinal studies are necessary to fill major research 
gaps in lesbian health; inclusive of the three research questions presented in this dissertation.  
Furthermore, more efforts are needed to explore different lesbian subgroups based on geographic 
location, race, age, socio-economic status, varying sexual orientations (bisexual and questioning 
women), and gender identities.  This will involve new innovative strategies to capture different 
female sexual minority populations.  A greater understanding of how sexual orientation may 
change over time in relationship to certain health behaviors, practices, and disease outcomes is 
essential.  Standard definitions of how lesbian and other sexual orientations are required to make 
comparisons across studies and to make more meaningful statements/conclusions about the state 
of lesbian health.  The three manuscripts presented in this dissertation make it clear that lesbian-
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specific health education, health programs, and interventions are needed to reach this population 
of women. Findings of this dissertation express the necessity for medical professionals and 
public health programs to acknowledge potential health disparities among lesbians and address 
the needs of sexual minority populations of women.   
6.5 CONCLUSIONS 
Understanding lesbian health and how it changes across the lifespan is a relatively new area of 
research.  This dissertation filled some essential research gaps in lesbian health through three 
epidemiological studies that explored CAM use, determinants of obesity, and PCOS prevalence.  
Despite this, more work is needed to further explain how each of these public health matters may 
vary between lesbian and heterosexual women, and how the medical health establishment, 
researchers, and community-health organizations can better serve the lesbian population.  
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APPENDIX A. ESTHER SCREENING FORM 
A.1 ESTHER SCREENING FORM 
Phone Screen Interview 
If 2004: born in 1969 – turn 35 
1.  Age: ___ (> 35 yrs)  2.  Date of Birth: ____/____/____ If 2005: born in 1970 – turn 35 
        If 2006: born in 1971 – turn 35 
 
3.  Which of the following best describes your racial/ethnic heritage?  (NOTE: Read all 
responses and check all that apply) 
  American Indian or Alaska Native 
  Asian 
  Black or African-American 
  Hispanic or Latina 
  Native Hawaiian or Other Pacific Islander 
  White 
  Other (Specify:__________________) 
 
4.  Have you ever been told by a doctor or other medical person that you have any of the 
           following conditions? 
If “yes”, Specify: 
 a. Angina     Yes   NO  ________________________ 
 b. Heart Attack                 Yes   NO  ________________________ 
5.   Have you ever had any of the following procedures?   If “yes”, Specify: 
a. Coronary Artery Bypass Surgery   Yes   NO ________________________ 
 b. Balloon Angioplasty/PTCA    Yes   NO ________________________ 
 c. Other surgical procedure involving  
                 the coronary arteries      Yes   NO ________________________ 
 
   83
6. Are you presently being treated by a physician or health care provider for any other 
health problem? 
 
  Yes   No  
If “yes”, specify___________________ 
I mentioned before that one of the lifestyle differences we are looking at is sexual orientation. 
Now I would like to ask you a few questions about how you identify yourself. 
 
7. How do you identify your sexual orientation? 
 
 
 
 
 
 
 
 
 
 
 
 
ELIGIBLE: 
 Heterosexual Women = Heterosexual (#7) + Only Men (#8) 
 Lesbian Women =  Bisexual (#7) + Primarily Women OR Only Women (#9) 
    Lesbian (#7) + Primarily Women OR Only Women (#9) 
    Other (#7) + Primarily Women OR Only Women (#9) 
 
  Heterosexual or 
Straight   
      Ask question #8 only) 
8. Since age 18, have your 
sexual partners been… 
 
  Only men 
  Both men and women 
  Only women 
  Bisexual (Ask question #9 only) 
  Lesbian or Gay (Ask question #9 only) 
       Other (Specify) _______ (Ask question #9) 
9.  Over the past five years, has your emotional,  
physical, and romantic attractions been towards 
  Only women 
  Primarily women 
  Women and men equally (ask 
question #10) 
  Primarily men 
  Only men 
10. Over the past five years have your relationships 
been    
  Only women 
  Primarily women 
  Women and men equally  
  Primarily men 
  Only men 
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APPENDIX B.  PAPER ONE APPENDICES  
B.1 QUESTIONNARES 
B.1.1  ESTHER Questionnaire 1 
1.  Which of the following categories comes closest to the type of place where you presently live?  
(The city of Pittsburgh would be categorized as a large city.) 
 
1 q In open country but not on a farm    
2 q On a farm     
3 q In a small city or town (under 50,000 residents) 
4 q In a medium-size city (50,000 – 250,000 residents) 
5 q In a suburb near a large city 
6 q In a large city (> 250,000 residents) 
 
7. Which of the following categories represents your total household income from all sources? 
 
1 q Less than $15,000      
2 q $15,000 - $24,999      
3 q $25,000 - $39,999 
4 q $40,000 - $59,999 
5 q $60,000 - $74,999 
6 q $75,000 or more 
 
      10.  What is the highest grade or year of school you have completed? 
1 q Less than 12 years    
2 q High school diploma or GED   
3 q Some college, 2-year degree or diploma, technical school 
4 q Bachelor’s degree 
5 q Graduate or professional degree 
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Please read the following list of the ways you may have felt or behaved recently. For each statement, 
place an “X” over the box indicating how often you have felt this way during the PAST WEEK. 
 
     
 
 
 
 
Rarely or 
none of the 
time (less 
than 1 day) 
 
Some of the 
time (1-2 
days)
Occasionally 
(3-4 days)
Most of the 
time (5-7 
days)
 
  
 
18. I was bothered by things that 
don’t usually bother me. 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
19. I had trouble keeping my 
mind on what I was doing. 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
20. I felt depressed. 
 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
21. I felt everything I did was an 
effort. 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
22. I felt hopeful about the 
future. 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
23. I felt fearful. 
 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
24. My sleep was restless. 
 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
25. I was happy.            
1 q 
         
2 q 
       
3 q 
         
4 q 
26. I felt lonely.            
1 q 
         
2 q 
       
3 q 
         
4 q 
27. I could not “get going.” 
 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
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B.1.2  ESTHER Questionnaire 2 
1.  In general, how would you characterize your health? 
 
1 q Excellent      
2 q Very good      
3 q Good 
4 q Fair 
5 q Poor 
6 q Very poor 
 
6.  Do you have a clinic, doctor, nurse, or physician’s assistant who provides your usual health 
care? 
  
1 q Yes 
0 q No 
 
8. About how long has it been since you last visited a doctor for a routine checkup? 
 
1 q Within the past year (anytime less than 12 months ago)  
2 q More than 1 year but less than 2 years ago 
3 q More than 2 years but less than 3 years ago 
4 q More than 3 years but less than 5 years ago 
5 q 5 or more years ago 
-8 q Don’t know/Not sure 
 
 
9.  Do you have any kind of health care coverage, including health insurance, prepaid plans 
such as HMOs, or government plans such as Medicare? 
 
1 q Yes  0 q No  [Go to Question 10 ] 
 
 
 
A. Is your health insurance under the coverage of a partner or spouse? 
 
1 q Yes     0 q No  [Go to Question 10 ] 
 
 
B.  If needed, could you obtain health insurance yourself? 
 
                     1 q Yes                       0 q     No     
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34.  Have you ever sought help from any type of alternative health services, such as traditional 
healing, acupuncture, massage, or herbal therapies?  EXCLUDE CLERGY AND 
CHIROPRACTORS. 
 1 q Yes   0 q No 
 
 
 
       35.  Have you sought help from any type of alternative health services in the last 12 months? 
 
  1 q Yes  0 q   No 
 
 
 
      
 
     A.  Which of the following have you used in the last 12 months?  
            (Check all that apply.) 
 
    1 q Acupuncture              
    2 q Aromatherapy             
    3 q Biofeedback             
    4 q Herbal medicine         
                  5 q Homoeopathy                                       
                  6 q Hypnosis                                                
                  7 q Massage                                           
                  8  q Meditation                     
                  9 q Reiki 
               10 q Relaxation techniques 
               11 q Therapeutic touch 
               12 q Yoga 
               13 q Others (specify):________________________________ 
                                                       
                                     _________________________________ 
 
                                                    _________________________________ 
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B.1.3  ESTHER Questionnaire 3 
10. Has a doctor or other health care provider ever diagnosed you as having any of the following?  
If yes, are you currently being treated with medication or some other therapy? 
 
 Ever 
diagnosed
?
Currently 
being 
treated?
Specify 
treatment 
  
 N
o
   
Yes         
No     
Yes
 
   
 
a. High blood 
pressure 
0 
q 
 1 
q? 
0 
q 
1 
q? 
______________ 
 
b. High cholesterol 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
c. High 
triglycerides 
0 
q 
1 
q? 
0 
q 
1 
q? 
______________
d. Diabetes 0 
q 
1 
q? 
0 
q 
1 
q? 
______________
e. Angina 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
f. Heart attack 0 
q 
1 
q ? 
0 
q 
1 
q? 
______________
g. Other heart 
disease 
0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
h. Stroke 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
i. Ulcers (stomach) 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
j. Obesity 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
k. Eating disorder 
(anorexia, 
bulimia) 
0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
l. Depression 0 
q 
1 
q ? 
0 
q 
1 
q? 
______________
m. Anxiety 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
n. Arthritis 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
o. Breast cancer 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
p. Lung cancer 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
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q. Ovarian cancer 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
r. Cervical cancer 0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
s. Other cancer 
(specify): 
__________  
0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
t. Asthma 0 
q 
1 
q? 
0 
q 
1 
q? 
______________
u. Emphysema or 
chronic 
bronchitis 
0 
q 
1 
q? 
0 
q 
1 
q? 
______________
v. Over- or 
underactive 
thyroid 
0 
q 
 1 
q? 
0 
q 
1 
q? 
______________
w. Osteoporosis/Ost
eopenia 
0 
q 
1 
q? 
0 
q 
1 
q? 
______________
x. Autoimmune 
disease (e.g., 
Lupus, 
Rheumatoid 
arthritis) 
0 
q 
1 
q? 
0 
q 
1 
q? 
______________
 
15.   Has a doctor or other health care provider ever diagnosed you as having any of the following?  
        If yes, are you currently being treated with medication or some other therapy? 
 
Ever diagnosed? 
No   Yes  Age at first diagnosis 
o.  HIV/AIDS  0 q 1q ? _____ years 
B.1.4  ESTHER Take-home Questionnaire (T11) 
We are interested in learning about the importance of both spirituality and religion for participants in this 
study.  For some people, spirituality and religion may be very important. For other people, spirituality and 
religion may not be important at all. Please do not skip any item even if spirituality and religion are not 
important to you. Choose the answer that best describes what is true for you. 
 
35.  To what extent do you consider yourself to be a spiritual person?  Check the most appropriate 
        number. 
            
       Not religious at all                                                      Very religious 
         1 q            2 q                3 q                    4 q                     5 q 
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APPENDIX C.  PAPER TWO APPENDICES 
C.1 QUESTIONNARES 
C.1.1  ESTHER Questionnaire 1 
7.  Which of the following categories represents your total household income from all sources? 
 
1 q Less than $15,000      
2 q $15,000 - $24,999      
3 q $25,000 - $39,999 
4 q $40,000 - $59,999 
5 q $60,000 - $74,999 
6 q $75,000 or more 
 
      10.  What is the highest grade or year of school you have completed? 
1 q Less than 12 years    
2 q High school diploma or GED   
3 q Some college, 2-year degree or diploma, technical school 
4 q Bachelor’s degree 
5 q Graduate or professional degree 
 
 
14. What is your current relationship status? 
 
1 q In a committed relationship for _____years _____ months 
2 q Not in a committed relationship 
3 q Other (specify): _____________________________ 
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Please read the following list of the ways you may have felt or behaved recently. For each statement, 
place an “X” over the box indicating how often you have felt this way during the PAST WEEK. 
 
     
 
 
 
 
Rarely or 
none of the 
time (less 
than 1 day) 
 
Some of the 
time (1-2 
days)
Occasionally 
(3-4 days)
Most of the 
time (5-7 
days)
 
  
 
18. I was bothered by things that 
don’t usually bother me. 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
19. I had trouble keeping my 
mind on what I was doing. 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
20. I felt depressed. 
 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
21. I felt everything I did was an 
effort. 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
22. I felt hopeful about the 
future. 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
23. I felt fearful. 
 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
24. My sleep was restless. 
 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
25. I was happy.            
1 q 
         
2 q 
       
3 q 
         
4 q 
26. I felt lonely.            
1 q 
         
2 q 
       
3 q 
         
4 q 
27. I could not “get going.” 
 
 
           
1 q 
         
2 q 
       
3 q 
         
4 q 
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C.1.2  ESTHER Questionnaire 3 
11. Has a doctor or other health care provider ever diagnosed you as having any of the following?  
If yes, are you currently being treated with medication or some other therapy? 
 
 Ever 
diagnosed?
Currentl
y being 
treated?
Specify 
treatment  
 
 No    Yes         No  Yes   
 
 
K.  Eating disorder 
(anorexia, bulimia) 
0  1 ? 0  1 ? ______________
l.  Depression 0  1  ? 0  1 ? ______________
m.  Anxiety 0   1 ? 0  1 ? ______________
C.1.3 Take-Home Questionnaire 11 
50. Do you feel that you were sexually abused by a family member when you were growing up 
(before age 18)? 
 
         1 q  Yes                              0 q No 
 
 
51. Do you feel that you were sexually abused by someone other than a family member when you 
were growing up (before age 18)? 
 
         1 q  Yes                              0 q No 
 
 
52. Since age 18, was there a time when someone forced you to have sexual activity that you 
really did not want?  This might have been intercourse or other forms of sexual activity, and 
might have happened with a partner, spouse, lover, friend, as well as with more distant 
persons or strangers. 
 
         1 q  Yes                             0 q No 
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APPENDIX D.  PAPER THREE APPENDICES 
D.1 QUESTIONNARES 
D.1.1  ESTHER Questionnaire 1 
7.  Which of the following categories represents your total household income from all sources? 
 
1 q Less than $15,000      
2 q $15,000 - $24,999      
3 q $25,000 - $39,999 
4 q $40,000 - $59,999 
5 q $60,000 - $74,999 
6 q $75,000 or more 
 
      10.  What is the highest grade or year of school you have completed? 
1 q Less than 12 years    
2 q High school diploma or GED   
3 q Some college, 2-year degree or diploma, technical school 
4 q Bachelor’s degree 
          5 q    Graduate or professional degree 
 
14.  What is your current relationship status? 
 
1 q In a committed relationship for _____years _____ months 
2 q Not in a committed relationship 
3 q Other (specify): _____________________________ 
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D.1.2  ESTHER Questionnaire 3 
1.  At what age did you have your first menstrual period? 
1 q < 10 years of age 
2 q 10 
3 q 11 
4 q 12 
5 q 13 
6 q 14 
7 q 15 
8 q > 15 years of age 
2.  Have you had at least one period in the last 12 months? 
 
  1 q Yes 0 q   No 
   
 
 A. At what age did you stop having your menstrual period? 
 
__________ years of age 
 
B. Did your periods stop naturally or because you had an operation, 
radiation treatment, or some drug therapy? 
 
1 q Natural menopause 
2 q Surgical menopause (uterus and/or ovaries removed) 
3 q Radiation therapy 
4 q Drug therapy 
5q Other   (specify):  ______________________ 
 
C. During menopause (in the last 12 months while you were still having 
menstrual periods) did you have any of the following? 
 
Yes  No 
 
Hot flashes     1 q  0 q 
Vaginal dryness   1 q  0 q 
Dizziness     1 q  0 q 
             Feeling nervous or depressed 1 q  0 q 
 
 
Continue with Question 3 
 
 
 
 
 
 
Continue with question 2A on page 2. 
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A. What was the first day of your last menstrual period?  
  
____   ____  month  ____   ____  day ____   ____   ____   ____ year 
 
B. Thinking back over the last 12 months, in how many of those months did you have a 
period? 
 
_______ number of months  
 
C. What would you estimate was the length of your menstrual cycle during the last 12 
months?  The length of your cycle is the number of days between the first day of two 
consecutive periods. 
 
1 q < 21 days 
2 q 21-26 days 
3 q 27-32 days 
4 q 33-40 days 
5 q > 40 days 
 
D.  In the last 12 months have your periods…  
 
1 q become somewhat further apart? 
2 q become somewhat closer together? 
3 q become quite variable? 
4 q remained quite regular?  
 
 
7.  Have you had a hysterectomy or have you had one or both of your ovaries removed? 
 
   1 q   Yes  0 q   No [Go to Question 8]   
 
 
 
 A.  Please check the type of surgery and write your age when the surgery was                  
                     performed. 
 
 1 q A hysterectomy with both ovaries removed ?         _______ years of age 
 2 q A hysterectomy alone or with one ovary removed ? _______ years of age 
 3 q Both ovaries removed (no hysterectomy)  ?         _______ years of age 
-8 q Not sure/Don’t know type of surgery performed ?    _______ years of age 
 
 
8.  Have you ever had a wedge resection of one or both of your ovaries or “ovarian drilling”? 
 
1 q Yes ?   _______ years of age 
0 q No 
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11.  Have you had any other gynecological surgery or procedure? 
 
1 q Yes   0 q No  [Go to Question 12 ]  
 
 
 
A.  Please specify: 
 
____________________________ ?   _______ years of age 
 
____________________________ ?   _______ years of age 
 
 
 
 
12. Have you ever taken oral contraceptives (birth control pills) for any reason? 
 
 1 q Yes  0 q No [Go to Question 13 ]   
 
 
 
A.   At what age did you begin taking oral contraceptives?    
 
_____ years 
 
B.   Are you currently on oral contraceptives?   
 
1 q Yes  0 q No   
 
C.   How long have you been on or did you take oral contraceptives? List  
                    total time if you have used them more than once. 
  
_____ years _____ months 
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13. Other than oral contraceptives, have you ever used female hormones (estrogen or progesterone) 
that were prescribed by a doctor or healthcare provider?  These could have been in the form of 
a pill, skin patch, shot, or vaginal cream or suppository. 
 
1 q Yes  0 q     No [Go to Question 14 ]   
 
 
 
A.  At what age did you begin hormone therapy?    
 
_____ years of age 
 
B.  Are you currently on hormone therapy?   
 
1 q Yes  0 q No   
 
C.  How long have you been on or were you on hormone therapy?  List  
      total time if you have been on HRT (Hormone Replacement Therapy)  
                   more than once. 
 
_____ years _____ months 
 
 
 
14. Have you ever been pregnant? 
1 q Yes  0 q    No [Go to Question 15]   
 
 
A.  How many times have you been pregnant?  
1 q Once 
2 q Twice  
3 q Three times 
4 q Four or more times 
 
B.  How many pregnancies resulted in births (live born or stillborn children)? 
         0 q None 
1 q One 
2 q Two  
3 q Three 
4 q Four or more 
 
D. At what age did you give birth (live born or stillborn) for the first time?  
  __ years of age   
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15. Have you ever been diagnosed with any of the following conditions?  If yes, please indicate 
how old you were when you were first diagnosed.  
 
                  Ever diagnosed? 
  
Yes         
Age at first diagnosis 
 
NNo   
 
a. Endometriosis (fibroids in the uterus) 
 q 
1
q ? 
_____ years 
b. Fibrocystic Breast Disease 
 q 
1
q ? 
_____ years 
c. Chlamydia 
 q 
1
q ? 
_____ years 
d. Inflammation or blockage of Fallopian 
tubes  q 
1
q ? 
_____ years 
e. Pelvic Inflammatory Disease 
 q 
1
q ? 
_____ years 
f. Ectopic pregnancy 
 q 
1
q ? 
_____ years 
g. Polycystic ovaries 
 q 
1
q ? 
_____ years 
h. Infertility 
 q 
1
q ? 
_____ years 
i. Bacterial Vaginosis (yeast infection) 
 q 
1
q ? 
_____ years 
j. Human Papilloma Virus  
 q 
1
q ? 
_____ years 
k. Abnormal Pap tests (more than 2 in a 
row)  q 
1
q ? 
_____ years 
l. Gonorrhea 
 q 
1
q ? 
_____ years 
m. Genital herpes 
 q 
1
q ? 
_____ years 
n. Genital warts 
 q 
1
q ? 
_____ years 
o. HIV/AIDS 
 q 
1
q ? 
_____ years 
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20. Compared to most women, have you ever had an excessive amount of hair on any part of your 
body? 
 
1 q Yes  0 q    No  [Go to Question 21 ] 
 
 
 
A.  Where was the excessive hair growth?  (check all that apply) 
 
1 q Upper lip 
2 q Chin 
3 q Neck 
4 q Chest 
5 q Lower stomach 
6 q Inner upper thighs 
7 q Sideburns 
 
 
 
21. Did you have acne after your teen years? 
 
  1 q Yes  0 q   No  [Go to Question 22 ] 
 
 
 
A. For how many years?  
 
__________ years 
 
B. Where was (is) the acne located? 
 
1 q Face and head 
2 q Shoulder, back or chest 
3 q Face/head AND shoulder, back or chest 
 
C. Do you currently have acne? 
 
1 q Yes  0 q   No 
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22. For each of the areas of the body shown in the diagram below, mark the number (0-4) of the 
figure that best depicts the amount of hair you have in each area.  If you do not have any 
noticeable hair in a particular area, mark zero (0).   
 
 
 
   
 
0    1   2   3   4 
Upper Lip:           
q q q q q   
               
 
0    1   2   3   4 
Chin:                     
q q q q q     
 
 
 
0    1   2   3   4 
Chest:                    
q q q q q 
 
 
 
0    1   2   3   4 
Upper Abdomen:  
q q q q q 
 
 
 
 
0    1   2   3   4 
Upper Arm:          
q q q q q 
 
 
 
0    1   2   3   4 
Thigh:                    
q q q q q 
 
 
 
 
 
0    1   2   3   4 
Upper Back:          
q q q q q 
 
   101
23. Do you have any family members with Polycystic Ovary Syndrome (PCOS)?  This is a condition marked by menstrual irregularity 
and/or infertility, abdominal body weight gain ("apple shape") and sometimes increased body hair and severe acne. 
 
  
     1 q Yes          2 q Possible 0 q No [Go to Question 24 ]          -8 q Unknown [Go to Question 24 ] 
 
 
   
             
Which of the following blood relatives have been diagnosed with PCOS or it is suspected that  
they might have PCOS based on the symptoms described above.  If you do not have a sister or 
 daughter, please mark “Not Applicable.” 
 
 Not 
Applicable 
D
on’t know 
Diagnosed Suspected 
   No Yes How 
many? 
No Yes How 
many? 
a. Maternal 
Grandmother 
 
  -8 q 
0 
q  q   q  q 
  
b. Paternal 
Grandmother 
 
  -8 q 
0 
q  q   q  q 
  
c. Mother 
   
-8 
q 
0 
q  q   q  q 
  
d. Sister(s) 
 -7 q 
-8 
q 
0 
q q? ____  q q? ____  
 
e. Daughter(s) 
 
-7 
q 
-8 
q 
0 
q q? ____  q q? ____ 
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24. Have you ever taken antiandrogens (for example, Flutamide or Spironolactone)? 
 
1 q  Yes 0 q  No [Go to Question 25 ]  -8 q  Unknown [Go to Question 25 ] 
 
  
A.  Are you currently taking antiandrogens? 
 
1 q Yes 0 q   No [Go to Question 25 ] -8 q   Unknown [Go to Question 25 ] 
   
 
a. How long have you used them? _____ years _____ months 
 
b. Please list the name of the medication  _______________________________ 
 
 
25. Have you ever taken any medications to induce ovulation (for example, fertility drugs such as 
Clomid, Serophene, Pergonal, Metrodin, hcG)? 
 
  
1 q  Yes  0 q  No  -8 q  Unknown  
 
 
 
  
 
A.  Please list the medications, age when taken and number of cycles taken. 
 
Name of Fertility Drug Approximate age 
when  taken 
Number of cycles 
taken 
________________________________ _________ _________ 
________________________________ _________ _________ 
________________________________ _________ _________ 
________________________________ _________ _________ 
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D.1.3 Consent Form for Polycystic Ovary Syndrome (PCOS) Study 
    
 Graduate School of Public Health    
          Department of Epidemiology  
 
 
CONSENT TO ACT AS A PARTICIPANT IN A RESEARCH STUDY 
 
 
TITLE: Polycystic Ovarian Syndrome (PCOS)   
 
PRINCIPAL INVESTIGATOR:    Helen A. Smith, PhD Candidate (Epidemiology)  
           CO-INVESTIGATORS:    Michelle Danielson, PhD and Nina Markovic, PhD 
                                                    ESTHER Study 
                                                    134 Trees Hall 
                                                    University of Pittsburgh 
                                                    Telephone: 412.648.8447 (Nina Markovic, PhD) 
 
Why is this research being done? 
Polycystic Ovarian Syndrome (PCOS) is found in 4-10% of women in the general population 
and is associated with increased risk of infertility, cardiovascular disease (CVD), endometrial 
cancer (EC), and Type II diabetes. The purpose of this study is to examine if the symptoms of 
PCOS differ in women based on demographic, health, and lifestyle characteristics.  Findings of 
this study could help health care providers make available additional screenings for associated 
co-morbidities, information regarding symptomology of PCOS, and improved assessment tools 
for diagnosis of PCOS.  Intervention strategies could also be created to help manage the 
symptoms and risk factors of PCOS, specific to certain groups of women.    
 
What would I be agreeing to if I decide to be in this research study? 
If you choose to participate in this study by signing your name on page 2, you are agreeing to: 
• sign this form and complete the attached questionnaire.  Return them in the attached 
postage-paid envelope.  (If we do not receive these forms from you within 2 months, we will 
call you to see if you would prefer to complete the questionnaire by phone). 
• allow us to correlate the information you provide in the attached questionnaire with some of 
the information about yourself that you provided as a participant in the ESTHER Project. 
• allow an additional analysis of the blood that you provided as a participant in the ESTHER 
Project.  (You will not need to come into our offices for another blood draw).  The additional 
analysis will primarily examine testosterone levels.  Low levels of testosterone are typically 
present in women’s blood. 
 
What are the possible benefits from taking part in this study? 
You will not receive any direct benefit from participating in this research study.  We will provide 
you with a copy of the test findings.  We are hopeful though that the information we receive will 
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provide additional knowledge about Polycystic Ovarian Syndrome, which could potentially help 
other women.  
 
Will I be paid if I take part in this research study? 
You will not be paid to complete this questionnaire and for allowing additional blood analysis to 
be performed on your stored blood samples.  Your participation is completely voluntary.  If you 
decide not to participate, this decision will not affect your relationship with the ESTHER Project 
or with the University of Pittsburgh. 
 
 
If I agree to take part in this research study, will I be told of any new risks that may be 
found during the course of the study? 
Investigators will identify individuals who may have PCOS.  Once those suspected of having 
PCOS are identified, investigators will promptly contact each woman suspected of having PCOS 
by telephone. Investigators will discuss what PCOS is and suggest that each woman suspected 
of having PCOS follow-up with her primary healthcare provider.  
 
Will the information I provide be kept confidential? 
Yes, the completed questionnaire will only be labeled by an assigned research code number 
and will not be associated with your name.  In the same way, the analysis of your blood will also 
be labeled with this assigned code number.  We will do this to protect your privacy and 
confidentiality.  All records related to your involvement in this research study will be stored in a 
locked file cabinet with your ESTHER Project data.  While there is the possibility of an 
accidental breach of confidentiality, we are using these methods to minimize the possibility of 
this risk.  
 
************************************************************************************************************* 
If you have any questions or would like to discuss my study, contact Nina Markovic, PhD 
at 412.648.8447. 
 
If you want to participate, please sign below and print your name.  
 
VOLUNTARY CONSENT:  
I understand the purpose and procedures in the Polycystic Ovarian Syndrome study, and agree 
to participate. I understand that if I have questions these can be answered by Dr. Nina Markovic 
or PhD Candidate Helen Smith.  In addition, if I have questions or concerns about my rights as a 
research participant these can be addressed by the University’s Human Subject Protection 
Advocate 1-866-212-2668. 
__________________________________     ________________ 
Participant’s signature        Date 
 
__________________________________ 
Participant’s printed name 
 
 
If you do not want to participate in this study, do not sign the consent, check the box below, and 
return this form in the enclosed envelope.   
 
 
[   ] I do not wish to participate in this study. 
D.1.4 Mailed Questionnaire for Polycystic Ovary Syndrome (PCOS) Study 
Date:   _____/____/______                                  Participant ID Number: ______________________ 
          Mo. Day Year 
 
MENSTRUAL, HORMONE USE & MEDICAL HISTORY QUESTIONNAIRE 
**If you have any questions answering the following questions please call Nina Markovic, PhD at 412.648.8447. 
 
1. What is your date of birth?     _____/_____/_____  (Month/Day/Year) 
 
2. How old were you when you had your first menstrual period? _______ years  
*If you do not remember the exact age, please give your best estimate.  
 
In the following two sections “Hormone Use and Duration” and “Menstrual History When Not On Hormones or Pregnant” 
we are interested in knowing more about your use of hormones and menstrual cycles throughout several stages of your 
life, i.e. during your teen years, during your twenties, during your thirties, and so on. 
 
Hormone Use and Duration (Years/Months) 
 
The following questions refer to common hormones women use.  Please indicate if you have used or are using any 
of the following hormones and the length of time you used or have been using each item.  If you do not remember the exact 
number of years or months you used each item, please give your best estimate.  
 
EXAMPLE:  This is an example of how you should answer the questions on the next page.    
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A. Have you used oral contraceptives (i.e. birth control pills) or birth control patches during the following times in your 
life?  
 Teens or 
Younger 
20s 30s 40s 
□ Check here if under 
40 
50s 
□ Check here if under 
50
Oral Contraceptives (OC) or  
Birth Control Patches □ Yes   □ No □ Yes  □ No □ Yes  □ No □ Yes    □ No □ Yes       □ 
No 
 How long (in years/months) did 
you use this? 
 ↓ 
____Years 
____Months 
↓ 
____Years 
____Months 
↓ 
____Years 
____Months 
    ↓ 
____Years 
 ____Months 
    ↓ 
____Years 
____Months 
 
B. Have you taken progesterone (i.e. Provera) during the following times in your life?   
 Teens or 
Younger 
20s 30s 40s 
□ Check here if under 
40 
50s 
□ Check here if under 
50
 Progesterone □ Yes   □ No □ Yes  □ No □ Yes  □ No □ Yes    □ No □ Yes       □ 
No 
How long (in years/months)  did 
you use this? 
 ↓ 
____Years 
____Months 
↓ 
____Years 
____Months 
↓ 
____Years 
____Months 
    ↓ 
____Years 
 ____Months 
    ↓ 
____Years 
____Months 
 
 
C.  Have you used hormone replacement therapy (HRT) in the form of pills, patches, creams, gels, vaginal rings or 
suppository tablets during the following times in your life? 
 Teens or 
Younger 
20s 30s 40s 
□ Check here if under 
40 
50s 
□ Check here if under 
50
Hormone Replacement Therapy 
(HRT) □ Yes   □ No □ Yes  □ No □ Yes  □ No □ Yes    □ No □ Yes       □ 
No 
 How long (in years/months) did 
you use this? 
 ↓ 
____Years 
____Months 
↓ 
____Years 
____Months 
↓ 
____Years 
____Months 
    ↓ 
____Years 
 ____Months 
    ↓ 
____Years 
____Months 
 
 
 
 
D. To the best of my knowledge I have never used oral contraceptives, birth control 
patches, progesterone, hormone replacement therapy or any other form of 
hormones. 
□ True □False 
 
Menstrual History When NOT on Hormones or 
Pregnant 
 
Complete the following questions for the times when you were NOT using any type of 
hormone or pregnant.  The purpose of this section is to collect detailed information 
about the frequency of your menstrual cycle and the average number of days between 
your the first day of your periods.  We are looking for potential menstrual irregularities.  
Since hormones are often used to help regulate menstrual cycles, it is important you 
complete the following for the times when you were not using any hormones (e.g. oral 
contraceptives or birth control patches, progesterone, or hormone replacement therapy).  
 
A. IN YOUR TEENS or younger, what was your average number of periods a year 
when NOT on hormones or pregnant?  ________ Periods a Year 
□ Does not apply. I used hormones every year from age at first period to age 19. 
□ Does not apply. (I was 20 or older when I got my first menstrual period.) 
□ Does not apply. Specify:________________________ 
 
B. IN YOUR TEENS or younger, what was your average cycle length (the average 
number of days between the first day of your periods) when NOT on hormones or 
pregnant. 
□  <21 Days 
□ 22 - 26 Days 
□ 27 - 31 Days 
□ 32 - 40 Days 
□ >40 Days 
□ Does not apply. (I took hormones during this whole time period.) 
□ Does not apply. (I was 20 or older when I got my first menstrual period.) 
□ Does not apply. Specify:________________________ 
 
C. IN YOUR 20s, what was your average number of periods a year when NOT on 
hormones or pregnant?   
________ Periods a Year 
□ Does not apply. I used hormones every year from 20-29 
□ Does not apply. Specify:________________________ 
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D. IN YOUR 20s, what was your average cycle length (the average number of days 
between the first day of your periods) when NOT on hormones or pregnant. 
□<21 Days 
□ 22 - 26 Days 
□ 27 - 31 Days 
□ 32 - 40 Days 
□ >40 Days 
□ Does not apply, I used hormones every year from 20-29 
□ Does not apply. Specify:________________________ 
 
E. IN YOUR 30s, what was your average number of periods a year when NOT on 
hormones or pregnant?  
________ Periods a Year  
□ Does not apply. I used hormones every year from 30-39 
□ Does not apply. Specify:________________________ 
  
F. IN YOUR 30s, what was your average cycle length (the average number of days 
between the first day of your periods) when NOT on hormones or pregnant. 
□ <21 Days 
□22 - 26 Days 
□27 - 31 Days 
□32 - 40 Days 
□ >40 Days 
□ Does not apply. I used hormones every year from 30-39. 
□ Does not apply. Specify:________________________ 
 
G. IN YOUR 40s, what was your average number of periods a year when NOT on 
hormones or pregnant? 
 ________ Periods a Year 
□ Does not apply. I used hormones every year from 40-49. 
□ Does not apply. (I am not yet in my 40s.) 
□ Does not apply. Specify:________________________ 
 
H. IN YOUR 40s, what was your average cycle length (the average number of days 
between the first day of your periods) when NOT on hormones or pregnant. 
□ <21 Days 
□ 22 - 26 Days 
□ 27 - 31 Days 
□ 32 - 40 Days 
□ >40 Days 
□ Does not apply. I used hormones every year from 40-49 
□ Does not apply. (I am not yet in my 40s.) 
□ Does not apply. Specify:________________________ 
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I. IN YOUR 50s, what was your average number of periods a year when NOT on 
hormones or pregnant?  
________ Periods a Year 
□ Does not apply. I used hormones every year from 50-59. 
□ Does not apply. Specify:________________________ 
 
J. IN YOUR 50s, what was your average cycle length (the average number of days 
between the first day of your periods) when NOT on hormones or pregnant. 
□ <21 Days 
□ 22 - 26 Days 
□ 27 - 31 Days 
□ 32 - 40 Days 
□ >40 Days 
□ Does not apply. I used hormones every year from 50-59. 
□ Does not apply. (I am not yet in my 50s.) 
□ Does not apply. Specify:________________________ 
 
Medical History  
Have you ever been told by a doctor or other healthcare professional that you have or 
had any of the following health conditions: 
 
1.   Polycystic Ovarian Syndrome (PCOS)?   
*Note: PCOS is a syndrome and is different from only having polycystic ovaries.  
□ Yes □ No     □ Not Sure 
 
2.      Congenital adrenal hyperplasias? 
□ Yes □ No     □ Not Sure 
 
3.      Congenital androgen-secreting tumors? 
□ Yes □ No     □ Not Sure 
  
4.      Cushing’s syndrome? 
□ Yes □ No     □ Not Sure 
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D.1.5 Graduate School of Public Health - Nutrition Laboratory (Blood Assay Procedures) 
Facilities:  The Nutrition Laboratory is located in five rooms which occupy 2,000 square feet in 
the Department of Epidemiology at the University of Pittsburgh's Graduate School of Public 
Health.  The laboratory is equipped with two Sterilgard Biological Safety cabinets; an Abbott VP 
Supersystem Bichromatic Analyzer; a Clinical Diagnostics Atac 8000 Chemistry Analyzer; an 
Olympus AU400 Chemistry Analyzer; a Perkin-Elmer 8410 capillary gas chromatograph with 
FID detector and Shimadzu C-R3A integrator; a Perkin Elmer Clarus 500 gas chromatograph 
with an FID detector, an auto sampler, a HP Pentium 4  with a data handling system and a HP 
Laserjet 1300; a Waters HPLC System, (two 6000A pumps, WISP 712 automatic injector, 2996 
Photodiode array detector, 490 Programmable detector, a Pentium 2 Gateway computer, 
Millennia software, a HP Laserjet 2100); a Packard Cobra II Gamma Counter; a LS-S 
fluorescence spectrophotometer; a Carey 50 uv/visible spectrophotometer; 2 Centra GP8R 
refrigerated centrifuges; an Optima TLX ultracentrifuge; three -20ºC freezers; twenty -70ºC 
freezers; a Mettler H542 analytical balance; an APX-100 analytical balance; a Buchler Vortex-
Evaporator; a Hewlett-Packard 85 computer and a Northgate Slimline 333 computer system with 
a Panasonic VGR screen and Hewlett-Packard Laserjet III printer. 
 
Quality Control:  Outlines of the analytical procedures employed in the laboratory are given 
below.  Initially the accuracy and precision of each technique is verified.  Briefly, blanks, 
controls, samples and standards are ran on multiple occasions.  Accuracy is estimated by 
comparing values obtained for the reference controls with their stated values.  Precision is 
evaluated as the coefficient of variation both intra-assay and inter-assay (reported with procedure 
outline). 
 
Ongoing quality control is monitored by plotting the mean values and the difference between the 
duplicates for the control samples versus time.  The 95% and 99% confidence limits are 
indicated on the graphs.  The laboratory has maintained the required levels of proficiency to be 
included in the CDC-NHLBI Lipid Standardization Program since 1982. 
 
At quarterly intervals, the CDC sends 36 samples to be analyzed for total cholesterol (high:100 
to 400 mg/dl), total cholesterol (low:<100 mg/dl), HDL cholesterol and triglyceride.  Nine 
samples are analyzed weekly for four weeks.  The results are returned to CDC and the mean and 
standard deviation compared to the accepted mean and standard deviation. 
 
In February 2004, the laboratory obtained CLIA certification. The laboratory was found to be in 
complete compliance with both the state’s clinical laboratory regulation and those of the Centers 
for Medicare and Medicaid Services.  Accordingly, the laboratory became enrolled in a 
proficiency testing program organized by the College of American Pathologists (CAP).  Three 
times a year CAP sends samples for analysis of glucose, insulin, total cholesterol, HDLc and 
LDLc (both calculated and direct) and triglycerides.  Results are evaluated for accuracy and 
precision. 
  
Sample Collection.  Blood is collected at the antecubitial vein from subjects in a reclined 
position into red-top tubes (serum) and lavender tubes (EDTA, plasma) (Vacutainer, Becton-
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Dickinson).  The samples are kept on ice and centrifuged (1500g for 15 min at 4ºC) within 90 
min of collection.  The samples are then aliquoted (1 ml) and stored at -70ºC until analysis. 
 
Sample Shipment.  Samples are shipped to Pittsburgh (533 Parran Hall, GSPH, University of 
Pittsburgh, 130 DeSoto Street, Pittsburgh, PA  15261, Attention: Ms. B. Hauth) in accordance 
with Department of Transport regulations for biological hazards, overnight and on dry ice.  
Delivery on weekends should be avoided. 
 
Procedures: (Volumes refer to plasma/serum) 
 
Testosterone (50 µl of sample).  Total testosterone is measured in duplicate using a commercial 
EIA kit (DSL-10-4000) purchased from Diagnostic Systems Laboratories (Webster, Texas).  In 
brief, samples (50 µl serum or plasma) are mixed with enzyme conjugate solution and 
testosterone antiserum and incubated for one hour at room temperature with rapid shaking.  The 
plate is then washed x5, TMB chromogen solution added and the plate incubated at room 
temperature for 30 minutes with rapid shaking.  Stop solution (0.2 M H2SO4) is added and the 
absorbance read at 450 nm with background correction at 600 or 620 nm.  Standards (0.1 to 25 
ng/ml), blanks, controls and a pooled laboratory control are run with each assay. 
 
Sex Hormone Binding Globulin (SHBG) (50µL of sample). SHBG is measured using an 
ELISA procedure developed by ALPCO (#11-SHB HU-E01; Salem, NH). Briefly, 100 µL 
samples (10µL serum diluted to 100 µL with buffer) are placed in microtitration wells coated 
with a monoclonal antibody specific for SHBG. The plates are incubated for 30 minutes at room 
temperature with shaking (200 rpm). The plates are washed with 300 µL buffer three times and 
150µL of conjugate solution (a monoclonal antibody to SHBG conjugated with horseradish 
peroxidase) and incubated for 15 minutes at room temperature with shaking. The plates are 
washed three times and 150 µL of TMB substrate added and the plates incubated at room 
temperature for 10 to 15 minutes with shaking. Stop solution, 50 µL, is added to each well and 
the optical density measured at 450 nm within 20 minutes. Standards (0.3 nM to 295 nM), 
blanks, calibrators and control pools are run simultaneously with all samples. 
 
Androstenedione  (100 µL of sample). Androstenedione is measured using an ELISA procedure 
developed by ALPCO (#11-ANRHU-E01; Salem, NH). In brief, samples (25 µL) are placed in 
microtitration wells coated with rabbit anti-androstenedione antibody. To each well 100 µL of 
androstenedione-horseradish peroxidase conjugate is added and the plates incubated at room 
temperature for one hour with shaking (200 rpm).  The plates are washed with 300 µL of buffer 
three times and 150 µL of TMB substrate then added. The plates are incubated at room 
temperature for 10-15 minutes with shaking.  Stop solution, 50 µL is added to each well and the 
optical density measured within 20 minutes at 450 nm. Standards (0.1 to 10 ng/mL), blanks, 
calibrators and control pools are run simultaneously with all samples. 
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